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ABSTRACT
Exosomes are vesicles secreted by cells having a size range from 30-150 nm and
carrying genetic materials that are important for intercellular functions. Besides, mounting
evidence suggests that tumor cells secrete more exosomes than normal cells making it
important to quantify exosomes as well. Thus, it is important to be able to efficiently isolate
and quantify exosomes for potential use in clinical diagnostics, as well as to develop a
deeper understanding of their role in intercellular processes. Apart from exosomes,
Lentivirus is another bioparticle that has drawn great attention from researchers. Lentivirus
is a genus of retroviruses with a size range of 80–100 nm in diameter and is increasingly
used as gene delivery vehicles for vaccines and immunotherapies. However, the
purification of clinical-grade lentivirus vectors for therapeutic use is still troublesome and
limits preclinical and clinical experiments. Traditional methods for exosome and
lentiviruses isolation and quantification are time-consuming, have low purity yields (i.e.,
high protein carryover), and may cause exosome aggregation. Therefore, a better isolation
and quantification method for exosomes and lentiviruses is required.
In the last two decades, Marcus and coworkers have successfully employed
capillary-channeled polymer (C-CP) fibers as the stationary phase for protein and IgG
separations via reversed-phase (RP), ion exchange (IEX), hydrophobic interaction (HIC),
and affinity chromatography. In this study, we have used the C-CP column for the study
on isolation and quantification of exosomes from human urine, blood plasma, and cell
culture media, and that of lentivirus from cell culture media. To improve the isolation
quality, different parameters, such as flow rates, column lengths, modifiers (acetonitrile
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and glycerol), separation modes (linear-gradient and step gradient), were optimized. The
process has been verified via analytical instruments such as scanning electron microscopy
(SEM), transmission electron microscopy (TEM), enzyme-linked immunosorbent assay
(ELISA), and quantitative polymerase chain reaction (qPCR), were used for characterizing
the exosomes and lentiviruses. In addition, a rapid, low-cost, and efficient reversed-phase
HPLC method for protein separation of proteins of wide-ranging molecular weights was
developed with novel polypropylene Y-shaped (trilobal) (PPY) C-CP column. In this
study, we have shown the capability of using the C-CP column for the separation of
exosome, lentivirus, and proteins with the optimized parameters.
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CHAPTER I
INTRODUCTION
1.1 Exosomes and its traditional isolation/quantification methods
Exosomes, a subset of the family of extracellular vesicles, are membrane-bound
vesicles and ranging from 30 to 150 nm in diameter. They are secreted by virtually all cell
types and found in most body fluids, including blood, urine, cerebrospinal fluid, breast
milk, and saliva, under both healthy and morbid conditions.1-3 Exosomes carry diverse
cellular constituents derived from their parent cells, including DNA, messenger RNAs
(mRNAs), microRNAs (miRNAs), proteins, and other biomolecular compounds.
Additionally, their surfaces are decorated with membrane proteins from their cell of origin.
They are important in intracellular communication and play key roles in many intercellular
functions, including immunomodulation, differentiation, antigen presentation, and cancer
progression.4 Importantly, mounting evidence suggests that tumor cells secrete more
exosomes than normal cells.5-7
These features have prompted research into the isolation and quantification of
exosomes for disease diagnosis as exosomes may serve as biomarkers for a variety of
diseases and cancers, such as ovarian cancer, breast cancer, pancreatic cancer, and colon
cancer.3,4 Of growing importance is the potential to use these vesicles a delivery vehicles
for therapeutic agents.8,9
The most popular method of exosome isolation is ultracentrifugation (UC), which
affects their physical separation from most other soluble components.10,11 However, several
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studies have reported that ultracentrifugation may cause aggregation or morphological
changes to the exosomes and other exosomes,12,13 which could cause artifacts, leading to
erroneous conclusions about exosome composition or phenotype. Additionally, the
ultracentrifugation method is time consuming (> 2 h), has low purity yields (i.e., high levels
of protein carryover), and only a small fraction of exosomes (<5%) in a specimen are
isolated.14,15 Another popular isolation method is ultrafiltration, in which a cellulose
membrane and multiple subsequent centrifugation steps are required. Unfortunately,
ultrafiltration can also cause exosome and co-purifying protein aggregation and is not time
efficient.16 Size exclusion chromatography (SEC) is growing as a potential separation
scheme with regard to throughput, but the method also leads to extensive dilution of the
sample and only permits efficient isolation of exosomes larger than the pore size of the
matrix used.17-20 Similarly, other exosome isolation methods such as gravitational size
exclusion chroatography,18,21,22 immunoaffinity capture,23,24 and precipitation25 either lead
to the dilution of exosomes, cause aggregation or lead to morphological changes. To be
clear, there is a broad spectrum of needs in terms of exosome isolation, from very generic
with relatively high volumes and throughput to highly specific capture on clinical size and
time scales.
In virtually every case, the exosome isolation and quantification operations are
performed as discrete processes. Current quantification methods include nanoparticle
tracking analysis (NTA), tunable resistive pulse sensing (TRPS), vesicle flow cytometry,
surface plasmon resonance (SPR), immunoaffinity capture, electron microscopy, and
optical fluorescence.26 These methods face as many challenges as the variety of isolation

2

methods do in terms of trade-offs between sensitivity, selectivity, and throughput.
However, while the above methods enable one to isolate or quantify exosomes, very few
advances have combined isolation and quantification into a singular operation scheme.
Within this area, the ExoChip,27 fluorescent nanoparticles,28 and ELISA-based
immunoaffinity capture 29,30 have been used for isolation and quantification of exosomes
from cell culture media and some body fluids. While sensitive for the targeted exosomes,
Many of the methods require use of either fluorescence or antibody tags, which are
expensive and time-consuming to effect. In nearly all cases, the capital and operational
costs are very high, with the specific training required for complicated sample preparation
procedures further increasing the overall cost. Thus, there is a high demand to find methods
to simultaneously isolate and quantify exosomes efficiently and stably, while allowing high
throughput and purity from latent proteins.
1.2 Lentiviruses and its traditional isolation/quantification methods
Apart from exosomes, lentivirus is another bioparticle that has drawn great
attention of researchers. Lentivirus is a genus of retroviruses with a size range of 80–100
nm in diameter and has emerged as a promising tool for vaccination31, gene therapy32, and
cancer immunotherapy33. Along with the increasing use of lentiviral vectors, the demands
for highly efficient purification procedures with improved process safety and throughput
for the generation of these vectors are also increasing

34,35

. Ultracentrifugation36 and

ultrafiltration37 are normally used as the method for lentivirus purification. However, these
methods generally require longer processing times (> 3 h), with post-isolation assays
typically revealing the presence of residual cellular debris, membrane fragments, and the
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denatured proteins derived from the culture media

38

. These impurities may be toxic to

lentivirus-treated cells, particularly primary cells, reducing transduction efficiencies, and
potentially causing immunogenic reactions in experimental animal models and the human
body

39,40

. Other separation methods for lentivirus purification include ion-exchange

chromatography (IEC) 38, affinity chromatography 41, size exclusion chromatography 42,
and sucrose gradient centrifugation 43. Unfortunately, these methods can require complex
protocols, specialized equipment, and expensive materials/chemicals, and are inefficient
with regards to the yields and purity of the lentivirus products. The challenges as they
relate to standard porous bead chromatographic media used in IEC emanate from the
combination of the large physical size of the particles (~100nm; creating poor mass transfer
characteristics and limiting surface interaction) and the chemically-complex nature of their
membrane envelope surfaces. As presented by Jungbauer et. al

44,45

, such vesicular

modalities call for the consideration of different chromatographic phase formats.
Ultimately, a simple and low-cost purification method for lentivirus recovery is desired to
reduce the carryover of potentially toxic culture by-products and increase processing
reliability.
1.3 Hydrophobic interaction chromatography method
Hydrophobic interaction chromatography (HIC) is a mode of separation in which
molecules (usually proteins) in a high salt concentration environment interact
hydrophobically with the less-polar surfaces of the stationary phase,46 a variant of the
common ‘salting out’ mode of protein purification. Elution is affected by reduction of the
solvent salinity, re-solvating the molecules into the eluate flow. HIC is a gentler method
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than reversed phase (RP) chromatography where a high concentration of organic solvent
elution is employed, maintaining the structural integrity and biological activity of the
biomolecules. In many instances, the selectivity and resolution of HIC separations are
improved by the addition of solvent modifiers, such as alcohols (mainly methanol, ethanol
and glycerol), acetonitrile (ACN), detergents, and chaotropic salts.47 In this study, ACN
and glycerol were selected and compared as a modifier for the HIC method.
1.4 Introduction of capillary-channeled polymer (C-CP) fibers

Fig. 1.1. SEM images of C-CP fiber columns. a) and c) cross section of PET C-CP column; b) and
d) cross section of PPY C-CP column

In the last two decades, Marcus and coworkers have successfully employed
capillary-channeled polymer (C-CP) fibers as the stationary phase for protein and IgG
separations via reversed phase (RP),48 ion exchange (IEC),49,50 hydrophobic interaction
(HIC),51 and affinity chromatography.52,53. C-CP fibers are extruded from polypropylene
(PP), polyester (PET), and nylon 6-based polymers in the form of 30–50 𝜇m diameter
fibers having eight channels running along their periphery.54,55 Importantly, the 1–4 μm
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spacing between the fiber channels provides free flow of proteins in viscous media without
significant fouling.55,56 In fact, the construct provides for protein separations at
significantly lower back pressures (< 1000 psi) and higher linear velocities (> 50 mm s−1)
than traditional porous bead support phases.
Recently, a Y-shaped trilobal, polypropylene fiber structure (referred to as PPY)
(Fig. 1.1b and 1.1d) was described and its performance compared to the typical eightchanneled shape (Fig. 1.1a and 1.1c) for reversed-phase protein separations.57,58
Ultimately, with more uniform packing (lower van Deemter A-term), the PPY columns
yield elution peaks with greater symmetry and higher separation efficiency (resolution)
than the previous eight-channel fiber geometry.57,58 As found previously,56 the fibers of
very limited porosity, thus the PPY column could ideally be used for the separation of
proteins via reversed-phase method.
1.5 List of Publications
The following chapters in this dissertation are based on these papers.
Chapter II: Huang, S., Wang, L., Bruce, T. F., & Marcus, R. K. (2019). Isolation
and quantification of human urinary exosomes by hydrophobic interaction chromatography
on a polyester capillary-channeled polymer fiber stationary phase. Analytical and
bioanalytical chemistry, 411(25), 6591-6601.
Chapter III: Huang, S., Wang, L., Bruce, T. F., & Marcus, R. K. (2020). Evaluation
of exosome loading characteristics in their purification via a glycerol-assisted hydrophobic
interaction chromatography method on a polyester, capillary-channeled polymer fiber
phase. Biotechnology progress, 36(5), e2998.
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CHAPTER II
ISOLATION AND QUANTIFICATION OF HUMAN URINARY EXOSOMES BY
HYDROPHOBIC INTERACTION CHROMATOGRAPHY ON A POLYESTER
CAPILLARY-CHANNELED POLYMER FIBER STATIONARY PHASE
2.1 Abstract
Exosomes are vesicles secreted by cells having a size range from 30 to 150 nm and
carrying genetic materials that are important for intercellular functions, including cancer
progression. Mounting evidence shows that tumor cells secrete more exosomes than
normal cells. Thus, it is important to be able to efficiently isolate and quantify exosomes
for potential use in clinical diagnostics, as well as to develop a deeper understanding of
their role in intercellular processes. Current methods for exosome isolation and
quantification are time-consuming and expensive. Few of these methods are able to
combine exosome isolation and quantification into a singular operation scheme. However,
a new efficient, rapid, and low-cost isolation and quantification method for exosomes in
human urine samples using polyester (PET) capillary-channeled polymer (C-CP) fibers in
a hydrophobic interaction chromatography (HIC) protocol has been developed. The
process has been verified via scanning electron microscopy (SEM) before and after the
capture of exosomes on the fiber surfaces. Sample load and elution rates were optimized
to affect high resolution and throughput. Isolated exosomes were quantified based on a UV
absorbance response curve created using a commercial human urine-derived exosome
standard with an exosome concentration of 7.32 × 1011 mL−1. The loading capacity of a 30-
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cm C-CP PET column was ~ 7 × 1011 exosomes. An inter-injection washing method with
PBS was developed to improve the reproducibility with a 2.9% RSD achieved for 7
complete isolation cycles.
2.2 Introduction
Exosomes are membrane-bound vesicles ranging from 30 to 150 nm in diameter.
They are secreted by virtually all cell types and found in most body fluids, including blood,
urine, cerebrospinal fluid, breast milk, and saliva, under both healthy and morbid
conditions.1-3 Exosomes carry diverse cellular constituents derived from their parent cells,
including proteins, messenger RNAs (mRNAs), microRNAs (miRNAs), and DNA.
Additionally, their surfaces are decorated with membrane proteins from their cell of origin.
They are important in intracellular communication and play key roles in many intercellular
functions, including immunomodulation, differentiation, antigen presentation, and cancer
progression.4 Importantly, mounting evidence suggests that tumor cells secrete more
exosomes than normal cells.5-7 These features have prompted research into the isolation
and quantification of exosomes for disease diagnosis as they may serve as biomarkers for
a variety of diseases and cancers, such as ovarian cancer, breast cancer, pancreatic cancer,
and colon cancer.3,4 There is also a sector of biotherapeutics researchers who are working
to develop exosomes as cell-specific delivery vehicles.8
Several

methods

have

been

used

for

exosome

isolation

including

ultracentrifugation,9,10 differential centrifugation ,11,12 size exclusion chromatography,13,14
immunoaffinity capture,15,16 and polymer precipitation.17
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Ultracentrifugation and differential centrifugation are the most commonly used methods
for isolating exosomes. However, they are time-consuming, have low purity yields (i.e.,
high protein carryover), and may cause exosome aggregation.18 Size exclusion
chromatography (SEC) is growing as a potential separation scheme with regard to
throughput, but the method also leads to extensive dilution of the sample and only permits
efficient isolation of exosomes larger than the pore size of the matrix used.10,14,19,20 The
immunoaffinity capture method is costly, is not suited for large sample volumes, and only
functions for exosomes having targeted proteins on their surface.16 To be clear, there is a
broad spectrum of needs in terms of exosome isolation, from very generic with relatively
high volumes and throughput to highly specific capture on clinical size and time scales.
Beyond isolation and identification of exosome populations, there is also a need to
quantify exosome isolates. Current methods include nanoparticle tracking analysis (NTA),
tunable resistive pulse sensing (TRPS), vesicle flow cytometry, surface plasmon resonance
(SPR), immunoaffinity capture, electron microscopy, and optical fluorescence.21 These
methods face as many challenges as the variety of isolation methods do in terms of tradeoffs between sensitivity, selectivity, and throughput. However, while the above methods
enable one to isolate or quantify exosomes, very few advances have combined isolation
and quantification into a singular operation scheme. Within this area, the ExoChip,22
fluorescent nanoparticles,23 and ELISA-based immunoaffinity capture 17,24 have been used
for isolation and quantification of exosomes from cell culture media and some body fluids.
While sensitive for the targeted exosomes, they tend to be low throughput and bring along
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high reagent and instrumentation costs. A missing tool in the realm of exosome diagnostics
and processing is a high-throughput, generic method of isolation and quantification.
Given the potential limitations of the methods described above, Marcus and coworkers recently demonstrated an exosome isolation and quantification method using poly
(ethylene terephthalate) (PET) capillary-channeled polymer (CCP) fibers in a hydrophobic
interaction chromatography (HIC) method.25 C-CP fibers are melt-extruded from
commodity polymers (nylon 6, polypropylene, PET) in the form of 30–50-μm-diameter
fibers, having eight channels running along their periphery. C-CP fiber columns have been
used for protein and IgG separations via reversed phase (RP),26 ion exchange (IEC),27,28
hydrophobic interaction (HIC),29 and affinity chromatography.30,31 Essential to the
application at hand, the surface of the fiber phase is effectively non-porous versus the size
of exosomes, so no intra-phase holdup occurs. Importantly, the 1–4 μm spacing between
the fiber channels provides free flow of exosomes in viscous media without significant
fouling. In fact, the construct provides for protein separations at significantly lower back
pressures (< 1000 psi) and higher linear velocities (> 50 mm s−1)32-34 than porous bead
support phases. In the described method, the extremely hydrophobic exosome surfaces first
adhere to the weakly ionized surfaces of the PET fibers under high salt ((NH4)2SO4)
concentrations. This process is then followed by a reversed salt gradient. Based on their
relative hydrophobicity, exosomes elute long after any latent protein species, making HIC
a selective method of exosome isolation, free from latent proteins. HIC is a gentler method
than RP (organic solvent) elution, maintaining the structural integrity and biological
activity of the exosomes. Quantification in this approach was affected using the standard
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absorbance detector of the HPLC system. By HPLC integration, including isolation and
quantification, this method provides a high-throughput and automated collection of
fractions, whereas manual processing (e.g., centrifugation) may introduce operator-based
variability, which may affect the purity of the fractions.14
In this study, we describe an efficient, low-cost, and gentle isolation and
quantification method for exosomes in human urine samples using PET C-CP fibers in a
hydrophobic interaction chromatography (HIC) protocol. Urine is a key sample matrix
utilized in many bioassays due to its ready availability, relatively large volumes, and the
“integrating” aspects of how urine is processed in the body. Different from other exosome
separation methods applied for urine, 35-37 following filtration using a 0.2-μm membrane to
remove large contaminants, such as cells, human urine was directly injected onto the fiber
column without any concentration steps or centrifugation. As such, this method not only
helps to maintain the structural integrity and biological activity of the isolated exosomes,
but also streamlines the overall process. The methodology used here was first evaluated
using conditions developed in the prior effort,25 with the capture of exosomes verified via
scanning electron microscopy (SEM). Based on the matrix complexity and the high affinity
of exosomes for the fiber surfaces, a post-injection washing method was developed to
improve the reproducibility. As is important in all chromatographic separations, the role of
the mobile phase velocities in both the injection and elution steps was evaluated.
Calibration functions were created using multiple volumes of a solution prepared from an
exosome standard as well as for the urine test matrix. In both cases, high fidelity linear
regressions were realized, though with a clear case of column overload observed for the
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injection of large volumes (> 1.0 mL) of urine. It is believed that the isolation of human
urinary exosomes using this straightforward method holds a great deal of promise in the
fields of clinical diagnostics and fundamental biochemistry research.
2.3 Material and methods
Chemicals and instrumentation
HPLC-grade acetonitrile (ACN) was purchased from EMD Millipore (Billerica,
MA, USA), ammonium sulfate was purchased from VWR (Sokon, OH, USA), sodium
phosphate dibasic was purchased from Sigma-Aldrich, and potassium phosphate
monobasic was purchased from Sigma. All aqueous solutions were prepared with ultrapure
water (18.2 M Ω cm) obtained from a Millipore water system (Billerica, MA, USA). The
PBS buffer was prepared by dissolving Na2HPO4 (1.42 g) and KH2PO4 (0.24 g) in
deionized water to a final volume of 1.0 L. The pH of the PBS buffer was adjusted to 7.4
using 4 M HCl. Exosome populations utilized as “standards” were purchased from
HansaBioMed Life Sciences (Tallinn, Estonia). (To be clear, these materials are not
certified reference materials.) In this case, lyophilized exosomes derived from human urine
from healthy donors, with a mass equivalent to a concentration of 1.45 × 1013 particles
mL−1 according to independent nanoparticle tracking analysis (NTA) results, were
employed. The exosome standards were reconstituted according to the manufacturer’s
directions to 1.45 × 1012 particles mL−1 with DI-H2O for further study. The human urine
was obtained from the Greenville (South Carolina) Hospital System, which had been stored
at − 80 °C.
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All chromatographic measurements were performed on a Dionex Ultimate 3000
HPLC system (LPG-3400SD quaternary pump and MWD-3000 UV–Vis absorbance
detector; Thermo Fisher Scientific, Sunnyvale, CA, USA) and controlled by the
Chromeleon 7 software system. UV detection at 216 nm was used as the post-column
detection. All isolated fractions from HPLC were collected by an R1 fraction collector
(Teledyne ISCO, Lincoln, NE, USA).
Microbore C-CP fiber column construction
The PET C-CP fibers were manufactured by the Department of Materials Science
and Engineering at Clemson University. The process of packing C-CP fibers into
microbore columns has been described in a previous communication.26 Eight rotations of
PET fibers (equaling 450 single fibers) were rinsed with hot water, acetonitrile,
isopropanol, and Milli-Q water then pulled through 30-cm polyether-ether-ketone (PEEK)
tubing with an inner diameter of 0.03 in. (0.76 mm) (IDEX Health & Science LLC, Oak
Harbor,WA, USA). After packing, the column was washed with Milli-Q water, ACN, and
Milli-Q water successively at 0.5 mL min−1 on the HPLC system until a stable baseline
was observed with the UV–Vis absorbance detector (216 nm). Once assembled and
cleaned, the microbore columns were stored at ambient conditions.
Liquid chromatography isolation and quantification method
The 30-cm PET C-CP fiber column was prepared as described above and inserted
in the normal position as any other chromatography column for the exosome isolation, with
the column operated at room temperature (~ 20 °C). The column was equilibrated with
buffer A (1.8 M (NH4)2SO4 solution dissolved in PBS, pH = 7.4), which also served as the
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loading medium. Buffer B (40% v/v ACN in PBS, pH = 7.4) was used as the
chromatographic elution solvent as described previously.25 It needs to be noted that a 20μL loop and 2-min loading time were used for the commercial exosome standard, while
the human urine sample was loaded twice and equilibrated in a 200-μL loop for 4 min
because of the lower exosome concentration in comparison with the standard. A 14-min
gradient from 100% buffer A to 100% buffer B was applied at a mobile phase flow rate of
0.5 mL min−1.
UV absorbance (technically scattering from the microbodies) at 216 nm was
monitored as a means of detecting the eluting species (proteins and exosomes). The
gradient baseline absorbance was obtained by running the gradient with no sample injected.
The absorbance baseline was subtracted from the exosome separation chromatograms. The
peak areas of the elution peaks were integrated and calculated through the Chromeleon 7
software system. Based on the detector response reflecting their elution, purified exosomes
were collected using the R1 fraction collector. The same isolation procedure was also
performed on the exosome standards across nine concentrations to generate response
curves, with the quantification of exosomes in the native urine sample calculated based on
the response functions.
On-fiber characterization of the exosomes
In order to verify their capture and characterize the microscopic morphology of the
exosomes on the C-CP fiber surfaces, a scanning electron microscope (Hitachi S-4800,
Tokyo, Japan) was used. The fiber columns were cut into 5-cm segments and installed on
the HPLC instrument, with 200-μL exosome samples loaded and eluted according to the
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HIC method previously described.25 Two column examples were collected; one before and
after the exosome elution processes. Each column was cut to 0.5-cm length and rinsed in a
mixture of 2% osmium tetroxide and 1.8 M (NH4)2SO4 solution (1:1 v/v) for 30 min to fix
and stain the captured exosomes. In order to remove the excess osmium tetroxide from the
fiber surfaces, 1 mL of distilled water was added in a centrifuge tube with the fibers and
spun for 5 min, followed by washing three times in distilled water, with 50%, 70%, 80%,
90%, 95%, and 100% ethanol and a 50–50 hexamethyldisilazane (HMDS)–ethanol for 3
min to remove the latent water. The fibers were then left in HMDS overnight until the
solution was fully evaporated. The fibers were extracted from the tubing and fixed to the
SEM holder using double-sided taped and then sputtercoated with platinum at 70 mTorr
argon for 2 min using a Hummer 6.2 Sputtering system (Anatech USA, Union City, CA).
The fibers were imaged via SEM, and ImageJ38 was used to analyze the size distribution
of the exosomes on the fiber.
2.4 Results and discussion
Isolation and characterization of exosomes in human urine
We recently reported a method via HIC with PET C-CP fibers, which provides an
efficient way to isolate exosomes.25 It is important to note that when using the commonly
applied differential centrifugation, ultracentrifugation, and several commercially available
kit isolation methods, there is still substantial carryover of undesirable sample impurities,
such as host cell proteins (HCPs). Given the time consumption and low specificity of these
methods, which are limiting in terms of development of downstream isolation and
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quantification of schemes, we have pursued a new method alleviating these pretreatment
steps and directly loading filtered human urine on to the C-CP fiber columns.

Fig. 2.1 HIC chromatograms of exosome isolation using PET C-CP fibers. Exosomes were eluted
from a) 200-μL human urine (injected twice), b) 20 μL of a commercial exosome standard
(HansaBioMed Life Sciences) derived from human urine, and c) 100-μL differential centrifugation
concentrated exosomes added to 100 μL of mock urine. Separations were performed with a mobile
phase flow rate of 0.5 mL min−1 and a 14-min gradient from100% buffer A (1.8M(NH4)2SO4
solution dissolved in PBS; pH = 7.4) to 100% buffer B (40% acetonitrile (v/v) dissolved in 1× PBS)

As the expected exosome sizes were between 30 and 150 nm, a 0.22-μm filter was
used to first remove the macroscale debris and other large-sized impurities from the urine
samples. Figure 2.1a presents the C-CP fiber HIC chromatogram resulting from the
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injection of the human urine sample. The very intense absorbance seen early in the
chromatogram reflects the injection peak and the elution of non-retained species, such as
salts and assorted small molecules, including urea. The broad peak between 4 and 11 min
represents two populations, the first most likely including small, non-polar molecules and
genetic material, with the latter being mainly proteinaceous material. The peak eluting
between 13.5 and 14.5 min corresponds to what is typical of exosomes under these
chromatographic conditions. As a point of comparison, the chromatograph in Fig. 2.1b
represents a sample of commercial, human urine–derived exosomes in a PBS matrix. In
this case, it is clear that there is still an appreciable amount of latent protein in the sample,
as those exosomes were likely isolated via centrifugation processing. As a final means of
assigning the elution time for the target exosomes, the standard exosomes were added to a
mock urine matrix. In this case, there is a preponderance of the small molecule eluates
relative to the proteins seen in the previous examples. Consistent across each of these
separations is the fact that the exosomes, regardless of source, tend to elute in the same
time windows and that those windows occur long after the other sample constituents have
passed from the column.
SEM images of the fibers before and after exosome elution confirmed that the
exosomes were eluted between 13.5 and 14.5 min. Fig. 2.2a (5.0-μm scale) reflects the
surface morphology of the fibers extracted from a column after the 11-min elution point,
wherein the impurities (salts, proteins) should have been eluted, but the exosomes are still
retained. ImageJ particle analysis38 of the frame depicted in Fig. 2.2a was undertaken to
assess the size distribution of those exosomes and is presented in Fig. 2.2b.
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Fig. 2.2 SEM images of exosomes immobilized on PET C-CP fibers following exposure to 600 μL
of human urine. a) Low magnification (scale = 5.0 μm) view, b) particle size analysis of ImageJ, c)
high magnification (scale = 0.5 μm), and d low magnification (scale = 5.0 μm) views following
exposure to the elution solvent

The size range from 60 to 250 nm, with approximately 85% of the exosome sizes
lying between 90 and 180 nm. Further magnification (× 10) of the exosome population
(Fig. 2.2c) provides indication as to why the size distribution is biased high as the exosomes
appear to spread non-uniformly on the surface, which is not surprising given the strong
hydrophobic interactions taking place. Even so, they remain completely intact. Previous
nanoparticle tracking analysis (NTA) indicated that once eluted, the exosomes return to the
expected size distributions.25 Finally, SEM imaging of the fibers extracted following the
complete chromatographic cycle (Fig. 2.2d) illustrates that the vast majority of the
exosome population is indeed removed from the fiber surfaces. In this case, the
micrographs of Fig. 2.2 a and d (taken at the same magnification) suggest elution
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efficiencies far exceeding 90%. Indeed, the particle that is present in the micrograph of Fig.
2.2d has the appearance of a salt crystal rather than a shape of an exosome.
Reproducibility of exosome isolation
While the material cost of each C-CP fiber column is less than $15, there would be
benefits in terms of costs and overall throughput if it was shown that each column could
be used in multiple exosome isolation runs. Given the tenacity of the exosome–fiber
surface interaction, carryover is a natural area of concern (though Fig. 2.2d suggests a very
efficient recovery/elution).

Fig. 2.3 Relative amounts of eluted exosomes for 7 complete chromatographic cycles. a) 7
repetitions involving no column washing step and b) the resulting exosome recoveries are plotted
as a function of the first injection response. c) 7 repetitions employing the column washing step
and d) the resulting exosome recoveries are plotted as a function of the first injection response.
Separations were performed with a mobile phase flow rate of 0.5mL min−1, and 200 μL of human
urine was injected twice prior to each isolation. The washing step included a 3-min gradient cycle
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that was performed from 100% PBS to 100% washing buffer (90% v/v ACN in water and 0.1%
TFA) with a flow rate of 1.0 mL min−1

It has been demonstrated that previous efforts using C-CP fiber protein A columns
for monoclonal antibody isolation from diverse media can be cycled many (at least 10)
times without extensive clean-in-place processing, with columns and ligands maintaining
high integrity and reproducibility.31 To test the robustness of the urinary exosome
separation method, seven consecutive injections/separations of the human urine samples
were performed.
As depicted in the chromatograms of Fig. 2.3a, it is clear that the overall recoveries
of the exosomes, and the concomitants, suffer with increasing numbers of cycles. More
quantitatively, the bar graph of Fig. 2.3b reflects the recoveries for the exosome elution
band, with the integrated peak areas decreasing by 20% between the first and second cycles,
dropping steadily to 22% (relative) for the final cycle. It is natural to consider whether or
not the reduced recoveries (for all of the solutes) are due to degraded initial retention or
poor elution from the fiber surfaces. As shown in the literature, on-column biological
impurities can be difficult to eliminate when using pure organic solvents such as
acetonitrile or methanol, while mixtures of organic solvents with acids can be effective.39,40
In general, a minimum of 20 column volumes of washing reagent are recommended when
regenerating columns.40 Since the volume of a 30-cm PET C-CP column is ~ 150 μL, at
least 3 mL of washing buffer would be required. To that end, a washing method was
developed in which a 3-min gradient cycle was performed from 100% PBS to 100%
washing buffer (90% v/v ACN in water and 0.1% TFA) with a flow rate of 1.0 mL min−1.
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In using a gradient versus a steady-state infusion, the solvent composition windows for
each of the potential remnant species are crossed. As shown in the chromatograms and bar
graph of Fig. 2.3 c and d, the reproducibility and recoveries of the target exosomes are
substantially improved, and this is true for the concomitants as well. In fact, the exosome
recovery for the seventh separation is 91% of that of the first cycle. More to the point, the
variability across the 7 replicates was 2.9 %RSD. This level of repeatability is essential in
any future hopes of performing quantitative exosome separations whether in the clinical
diagnostics or fundamental biochemistry arenas.
Quantification of exosomes in human urine test sample

Fig. 2.4 Response curve of commercial human urine–derived exosome standard prepared at a
concentration of 1.45 × 1012 particles per mL plotted as a function of injection volume in PBS.
Triplicate injections were performed for each sample volume

While the nanometer-sized vesicles do not technically absorb UV photons via
electronic/vibronic/rotational transitions, previous efforts have shown that the amount of
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light scattering was indeed proportional to their concentration in solution. The quantity of
the exosomes is proportional to the corresponding “absorbance” peak area according to
Beer’s law, and therefore, the exosomes can be quantified utilizing classic response curves,
relating recovered chromatographic peak areas to the number of exosomes injected oncolumn. Briefly, 20, 30, 40, 50, and 60 μL of the commercial exosome standard (1.45 ×
1012 particles per mL in PBS) were loaded onto the column and eluted using the gradient
elution program and cleaning protocol described above.
Table 2.1 Peak characteristics for commercial human urine–derived exosome standard isolation
with different loading volumes. Load/elute program is the same as in Fig. 2.1. Solution
concentration = 1.45 × 1012 particles mL−1 (n = 3 replicates for each injection volume)

20

Average Peak
Area
(mAU*min)
0.567

30

0.785

0.0212

4.35

40

1.078

0.0090

5.80

50

1.476

0.0052

7.25

60

1.785

0.0034

8.70

Loading
Volume (μL)

Standard Deviation
(mAU *min)

Number of Exosomes
(1010 particles)

0.0253

2.90

The data and regression statistics are presented in Fig. 2.4 in terms of the respective
injection volumes and the integrated absorbance yields, with the individual statistics for
each injection volume presented in Table 2.1. The agreement with linearity (R2 = 0.9905)
covers a range of 2.90–8.7 × 1010 exosomes. To determine the concentration of exosomes
in a human urine sample, 100 μL of the human urine was loaded and isolated using the
HIC method, yielding an average integrated absorbance of 1.466 ± 0.029 mAU min,
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representing an exosome loading of 7.3 × 1010, and thus, the concentration of exosome in
the urine sample was 7.3 × 1011 mL−1.
While “absorbance” would certainly not be expected to yield the most sensitive means of
detecting the presence of exosomes, it is surely the most practical means of quantification
when coupled to conventional HPLC systems. Preliminary limits of detection (LOD) were
determined, defined as:
𝐿𝑂𝐷 =

!"
#

(1)

where s is the standard deviation of the measurements of the sample having the lowest
concentration and m is the slope of the response calibration curve. As presented in Table
2.1, the standard deviation of the lowest concentration was 0.0253 mAU min, and the slope
of the curve was 0.216 mAU min per 1010 particles. These values yield an LOD of 6.38 ×
109 particles. In terms of a generic method of exosome isolation, the absolute value here
may not hold particular relevance, but may be useful in terms of screening different media.
Exosome loading capacity of C-CP fiber columns
In order to obtain the greatest recoveries of urinary exosomes, it is first necessary
to characterize the binding capacity of the fiber columns. Once this is known, subsequent
adjustments in column format may be made to accommodate desired exosome numbers for
further preparative uses, such as RNA sequence profiling or targeted drug delivery. To
evaluate the exosome loading capacity of the current 30-cm column format, different
volumes (0.2, 0.4, 0.6, 0.8, 1.0, and 1.2 mL) of the human urine sample (with the
concentration of 7.32 × 1011 exosomes per mL determined above) were injected and put
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through the HIC and cleaning protocols.

Fig. 2.5 Response curve for commercial human urine–derived exosomes at a concentration of 7.3×
1011 particles per mL plotted as a function of injection volume to determine column binding
capacity. Response function is derived from the first five data points. Triplicate injections were
performed for each sample volume

As depicted in Fig. 2.5 the response to the increased numbers of exosomes (increase
injection volumes) does indeed follow a linear function, up to the level of ~ 1 mL, where
the response appears to reach a limiting situation. While detailed isotherms are necessary
to assign a firm value, the response depicted suggests proportional loading up to a dynamic
binding capacity of ~ 7 × 1011 exosomes for the current C-CP fiber column format. Given
that the complete cycle illustrated here, including the column wash step, could be
completed in 30 min, and the dynamic binding capacity of exosomes through a 30-cm CCP
fiber column is ~ 7 × 1011 exosomes, the throughput of this exosome processing protocol
is ~ 2.3 × 1010 exosomes per minute. Use of a step gradient approach, wherein the matrix
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species pass in the injection peak, could reduce the process time by a factor of 3–4,
providing a throughput of ~ 1 × 1011 exosomes per minute for this microbore column
format. Future studies will utilize frontal analysis (breakthrough curves) and isothermal
fitting to determine the dynamic binding capacity more accurately.
Effect of loading and elution flow rates on separation efficiency and throughput
As stated previously, one of the primary drivers for the development of the C-CP
fiber exosome isolation method is enhanced process throughput versus centrifugationbased methods. Previous studies of the HIC method of protein separations on PET C-CP
fiber columns showed that increases in elution flow rate effect separation quality and
resolution in a positive manner.41 The reason for this improvement is the narrowing of peak
widths via lessened amounts of longitudinal diffusion (van Deemter B-term) in
combination with no solution–solid mass transfer limitations (van Deemter C-term).42,43
Thus, throughput and efficiency are improved. On the other hand, there are certainly kinetic
limitations in the course of the loading steps where adsorption kinetics can be limiting.
Thus, there are trade-offs in the rates of solvent flow during sample injection and elution.41
It is reasonable to hypothesize that the elution and loading flow rates would also affect the
column capacity and separation quality of exosomes.
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Fig. 2.6 Representative chromatograms of human urine–derived exosome isolation/recovery as a
function of mobile phase flow rates. a) Flow rate of the elution buffer varied at 0.3, 0.5, 0.7, and
0.9 mL min−1, respectively, with an injection flow rate of 0.5 mLmin−1, and b) flow rate of the
loading buffer varied at 0.3, 0.5, 0.7, and 0.9 mL min−1, respectively, while the elution buffer flow
rate was kept constant at 0.5 mL min−1. In both cases, two 200-μL injections were employed before
starting the elution program

To assess the effects of elution flow rates on urinary exosome separations, 200-μL
human urine samples (loaded onto the column twice) with a constant loading flow rate of
0.5 mL min−1 and eluted at different flow rates (0.3, 0.5, 0.7, 0.9 mL min−1) were
interrogated as shown in Fig. 2.6a. Consistent with all former protein separations on C-CP
fiber phases, higher flow rates (equivalent to velocities up to 30 mm s−1) have two primary
results, earlier elution times, and suppression of the absorbance responses for the exosome
solutes. The former occurs by virtue of faster elution following release from the fiber
surface, and the latter due to greater solution phase dilution in the absorbance cell.
Table 2.2 presents the particular exosome peak elution characteristics for the
different elution rates. The relative improvements (narrowing of peak widths) with
increasing elution flow rate are not as pronounced as those seen for proteins, but there are
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certainly practical advantages to be realized. The reduced absorbance at higher flow rates
is proportional to the dilution factors as the flow rates increase.
Table 2.2 Elution peak characteristics for human urine isolation at different injections (load) and
elution flow rates. Injection volume = 0.4 mL. Injection concentration = 7.3 × 1011 particles mL−1
Injection flow rate
(mL min-1)
0.5

Elution
Exosome
flow rate elution time
(mL min-1)
(min)
0.3
12.950

Elution
Resolution between Peak area
peak width impurities and exosome (mAU*min)
(W1/2, min)
0.589
1.10
40.845

0.5

0.5

11.797

0.517

1.12

33.718

0.5

0.7

11.223

0.476

1.16

25.246

0.5

0.9

10.843

0.470

1.22

19.326

0.3

0.5

11.620

0.481

1.25

35.502

0.5

0.5

11.700

0.480

1.25

31.504

0.7

0.5

11.617

0.459

1.28

26.771

0.9

0.5

11.593

0.465

1.28

26.279

In a similar manner, the elution flow rate was kept at the nominally low value of
0.5 mL min−1, while the loading flow rates varied (0.3, 0.5, 0.7, 0.9 mL min−1) as shown
in Fig. 2.6b and quantified in Table 2.2. In this case, the first visual difference is the
breadths of the injection peaks, which reflect the differences in the loading rates.
Otherwise, as expected, the eluting chromatograms have the same temporal characteristics,
with the primary changes seen in the absorbance values. Here, it is clear that higher load
rates, and thus shorter column residence times, result in lower loadings/recoveries; in this
case, approximately 25% lower for the fastest load velocity. In summary, low load rates
are preferable for overall recoveries, while use of high elution flow rates provides benefits
in terms of both resolution and process throughput. While the absorbance yields are
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sacrificed under these conditions, the absolute numbers of purified exosomes recovered,
which may be the practical processing metric, are the same. Clearly, more detailed studies
involving the isolation of exosomes on preparative scales are in order as one looks to
applications where high throughput, high purity, and high yield are required.
2.5 Conclusions
Due to the preponderance of exosomes in many biological processes and the
potential for their use in clinical diagnostics and drug delivery, there is a critical demand
for methods that provide access to these vesicles in diverse biological media. The concept
of using hydrophobic interaction chromatography (HIC) on polyester C-CP fiber columns
opens up a completely novel set of capabilities regarding throughput and the ability to
isolate exosomes from the potpourri of other concomitant sample constituents. We
demonstrate here the isolation of exosomes from a key biomatrix, human urine. Instead of
the use of multiple centrifugation and solid-phase extraction steps, sample volumes of
hundreds of microliter volumes are simply passed through standard 0.2-μm filters prior to
injection. HIC gradient programs of less than 15 min provide high levels of purity (isolation
from proteins, etc.) with a simple inter-separation cleaning protocol providing robust
results without carryover. The use of the standard UV absorbance detection scheme yields
a high level of correlation with the number of exosomes injected onto the column. Sample
load and elution rates were optimized to affect high resolution and throughput. Based on
the potential use of a step gradient approach, it is not unreasonable to expect that urinary
exosomes could be isolated in high purity and yield in time frames of less than 5–10 min
per sample. Based on the results of this study, the affordability and efficiency of isolation
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and quantification of exosomes in human urine samples can be significantly improved, and
the new method can be potentially adopted to applications in clinical and fundamental
biochemistry. Extensions to the realm of preparative scales are also a path forward.
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CHAPTER III
EVALUATION OF EXOSOME LOADING CHARACTERISTICS IN THEIR
PURIFICATION VIA A GLYCEROL‐ASSISTED HYDROPHOBIC INTERACTION
CHROMATOGRAPHY METHOD ON A POLYESTER, CAPILLARY‐CHANNELED
POLYMER FIBER PHASE
3.1 Abstract
Exosomes are membrane-secreted vesicles, with sizes ranging from 30 to 150 nm,
which play key roles in intercellular communication. There is intense interest in developing
methods to isolate and quantify exosomes toward clinical diagnostics, fundamental studies
of intercellular processes, and use of exosomes as delivery vehicles for therapeutic agents.
Current methods for exosomes isolation and quantification are time consuming and have
operational high costs; few combine isolation and quantification into a singular operation
unit. This report describes the use of hydrophobic interaction chromatography on a
polyester capillary-channeled polymer fiber column, employing a step gradient for
exosome elution, including use of glycerol as a solvent modifier. The entire procedure is
completed in 8 min, while maintaining the structural integrity and biological activity of the
isolated exosomes. Electron microscopy was used to verify the size and structural fidelity
of single exosomes. Absorbance response curves for a commercial exosome sample were
used for exosome quantification in the chromatographic separations. In order to determine
the dynamic loading capacity for exosomes, different volumes of Dictyostelium
discoideum cell culture milieu supernatant were loaded at different column lengths (5–30
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cm) and loading flow rates (0.2–0.5 ml min-1). A loading capacity of 5.4 × 1012 exosomes
derived from D. discoideum milieu was obtained on a 0.8 × 300 mm column; yielding
recoveries of over 80%. It is believed that this isolation and purification strategy holds
many advantages toward the use of exosomes across a wide breadth of medical and
biotechnology applications.
3.2 Introduction
Exosomes, a subset of extracellular vesicles (EVs), are membrane-secreted vesicles, with
sizes ranging from 30 nm to 150 nm, which exist in almost all cell types and body fluids
and play key roles in intercellular communication and cancer progression.1,2 Formed in
the multivesicular body (MVB), exosomes encapsulate various species including proteins
and genetic material, and carry along surface proteins representative of their source.
Notably, tumor cells have been shown to produce and secrete exosomes in greater numbers
than normal cells.3,4 These features have prompted continued research into the isolation
and quantification of exosomes for disease diagnosis as they may serve as biomarkers for
a variety of diseases and cancers.5-8 Of growing importance is the potential to use these
vesicles a delivery vehicles for therapeutic agents.9,10
The most popular method of EV isolation is ultracentrifugation (UC), which affects
their physical separation from most other soluble components.11-13 However, several
studies have reported that ultracentrifugation may cause aggregation or morphological
changes to the exosomes and other EVs,14,15 which could cause artifacts, leading to
erroneous conclusions about EV composition or phenotype. Additionally, the
ultracentrifugation method is time consuming, has low purity yields (i.e., high levels of
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protein carryover), and only a small fraction of exosomes (<5%) in a specimen are
isolated.2,16 Another popular isolation method is ultrafiltration, in which a cellulose
membrane and multiple subsequent centrifugation steps are required. Unfortunately,
ultrafiltration can also cause EV and co-purifying protein aggregation and is not time
efficient. 17 Similarly, other exosome isolation methods such as gravitational size exclusion
chroatography,18-20 immunoaffinity capture,21,22 and precipitation23 either lead to the
dilution of exosomes, cause aggregation or lead to morphological changes.
In virtually every case, the EV isolation and quantification operations are
performed as discrete processes. Current quantification methods include nanoparticle
tracking analysis (NTA), vesicle flow cytometry, tunable resistive pulse sensing, surface
plasmon resonance, immunoaffinity capture, electron microscopy, and optical
fluorescence.24 Many of the methods require use of either fluorescence or antibody tags,
which are expensive and time-consuming to effect. In nearly all cases, the capital and
operational costs are very high, with the specific training required for complicated sample
preparation procedures further increasing the overall cost. All of these quantification
methods are performed following the primary isolation process. Thus, there is a high
demand to find methods to simultaneously isolate and quantify exosomes efficiently and
stably, while allowing high throughput and purity from latent proteins.
Marcus and co-workers demonstrated an exosome isolation method using
poly(ethylene terephthalate) (PET) capillary-channeled polymer (C-CP) fibers in a
hydrophobic interaction chromatography (HIC) method.25-28 Previous works have
employed C-CP fibers extensively in intact protein separations via various modalities.29-33
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HIC is a mode of separation in which molecules (usually proteins) in a high salt
concentration environment interact hydrophobically with the less-polar surfaces of the
stationary phase,34 a variant of the common ‘salting out’ mode of protein purification.
Elution is affected by reduction of the solvent salinity, re-solvating the molecules into the
eluate flow. Previous studies of the HIC method for protein separation via PET C-CP fibers
showed potential attractive features in terms of protein throughput.33 In the method
described here, the hydrophobic surface of the EVs first adhere to the weakly-ionized
surfaces of the PET fibers under high ammonium sulfate concentrations (e.g., ~2 M
(NH4)2SO4). This process is then followed by the reversed salt gradient. Due to their
relative hydrophobicity, EVs elute long after any small molecules and proteinaceous solute
species, making HIC a selective method of EV isolation, free from other latent cellular and
media species. HIC is a gentler method than its sister reversed phase (RP) chromatography
where organic solvent elution is employed, maintaining the structural integrity and
biological activity of the EVs. On-line quantification was based on a UV absorbance
response curve created using a commercial human urine-derived exosome standard. Based
on our initial method,25 subsequent efforts have affected isolation and quantification of
EVs from complex biological fluids, including human urine,25,27

human plasma26,

reconstituted milk28 and cell culture milieu25 via HIC on a PET fiber stationary phase,
where the isolated EVs preserved intact morphology.27 These efforts provide a relatively
easy, low cost and efficient means for EV isolation and quantification using a simple high
performance liquid chromatography (HPLC) platform.

41

In many instances, the selectivity and resolution of HIC separations are improved
by the addition of solvent modifiers, such as alcohols (mainly methanol, ethanol and
glycerol), acetonitrile, detergents, and chaotropic salts.35 In the case of the previous HIC
fiber exosome separations, acetonitrile was used to this end.25,27 Glycerol is widely used
as a cryoprotectant in biology, where the glycerol is dissolved in water to reduce freezing
damage to diverse organisms.36-38 Glycerol is a nontoxic and compatible solute that has
few effects on enzymatic or metabolic processes even at very high concentrations.39 Studies
have also demonstrated that glycerol can improve the refolding of recombinant proteins in
HIC.40,41 These aspects suggest that glycerol would be a milder additive than acetonitrile,
suggesting that the HIC exosome isolation method with addition of glycerol could be an
efficient and mild way for the elution and storage of EVs. This concept has been
successfully demonstrated in this laboratory in the isolation of EVs from human plasma
and reconstituted milk.26,28
In this report, we describe an efficient, low-cost and gentle isolation and
quantification method for EVs derived from Dictyostelium discoideum (D. discoideum)
cell culture milieu using PET C-CP fibers in a glycerol assisted HIC protocol. D.
discoideum is a non-pathogenic eukaryotic microorganism, which offers a simple model
system of individual eukaryotic cells during growth.42,43 It is simple, efficient, and
inexpensive to culture this species, thus it has been chosen by the US National Institutes of
Health as a model organism for biomedical research and is an ideal model for the generic
study of EVs. In this method, cell culture milieu (supernatant) was filtered using a 0.2 µm
membrane and injected onto the fiber column without any pre-concentration or
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centrifugation steps. A step gradient HIC method was performed with glycerol as a
modifier, with the entire elution procedure completed in 8 minutes. Transmission electron
microscopy (TEM) imaging was used to verify the size and structural integrity of the
vesicles and NTA was used to characterize the size distribution and concentration of the
EVs. Response curves based on in-line optical absorbance detection were used for EV
quantification.

Different from typical evaluations of the loading capacities of a

chromatographic phase, this approach explicitly involves a purification step as well. As
such, buffer composition, bed size, and the process kinetics are interrelated. Loading
conditions were modified such that all undesirable culture components passed through the
columns unretained, leaving only the elution of purified vesicles. Different volumes of D.
discoideum milieu supernatant were loaded at different column lengths and loading flow
rates to evaluate the dynamic binding capacity (DBC) and the recovery of EVs toward EV
purification processing. It is believed that this method provides an affordable and efficient
means of isolation and quantification of EVs in cell culture samples, which can potentially
be adopted to a diverse range of biological media for applications in clinical and
fundamental biochemistry as well as large-scale EV production.
3.3 Materials and methods
Chemicals and instrumentation
Ultra-pure grade ammonium sulfate and biotechnology-grade glycerol were
purchased from VWR (Sokon, OH, USA), phosphate buffered saline (PBS) (10X) was
purchased from Hyclone Laboratories. Inc. (Logan, Utah, USA) and diluted with ultra-pure
water (18.2 M Ω cm) obtained from a Millipore water system (Biller-ica, MA, USA).
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HPLC-grade acetonitrile (ACN) was purchased from EMD Millipore (Billerica, MA,
USA).
Exosome populations utilized as “standards” were purchased from HansaBioMed
Life Sciences (Tallinn, Estonia). (To be clear, these materials are not certified reference
materials.). In this case, lyophilized exosomes derived from human urine from supposedly
healthy donors, with a mass equivalent to a concentration of 1.45 x 1013 particles mL-1
according to independent nanoparticle tracking analysis (NTA) results, were employed. D.
discoideum AX2 cells were cultured according to previous work.25 All ultracentrifugation
(UC) samples were performed at 12,000×g using a Beckman Coulter Avanti J-26S XPI
Centrifuge with a JA-25.50 rotor (Beckman Coulter, Brea, CA) for 1hr.
All chromatographic measurements were performed on a Dionex Ultimate 3000
HPLC system (LPG-3400SD quaternary pump and MWD-3000 UV–Vis absorbance
detector; Thermo Fisher Scientific, Sunnyvale, CA, USA) and controlled by the
Chromeleon 7 software system. While the nanometer-sized vesicles do not technically
absorb UV photons via electronic/vibronic/rotational transitions, previous efforts have
shown that the amount of light scattering was indeed proportional to their concentration in
solution.27 Detection at 216 nm was used post-column as in the case of a standard HPLC
experiment. Isolated fractions from the HPLC were collected using an R1 fraction collector
(Teledyne Isco, Lincoln, NE, USA).
The PET C-CP fiber column manufacture has been described in a previous
communication.44 Eight rotations of PET fibers (equaling 450 single fibers) were rinsed
with hot water, acetonitrile, isopropanol, and Milli-Q water then pulled through 30-cm
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polyether-ether-ketone (PEEK) tubing with an inner diameter of 0.76 mm (IDEX Health
& Science LLC, Oak Har-bor, WA, USA). After packing, the column was washed with
Milli-Q water, ACN, and Milli-Q water, successively, at a flow rate of 0.5 mL min-1 on the
HPLC system until a stable baseline was observed with the UV–VIS absorbance detector
(216 nm). Once assembled and cleaned, the microbore columns were stored at ambient
conditions. The columns were cut into 5 cm, 10 cm and 20 cm for the study of the
relationship between column length and binding capacity.
Liquid chromatography isolation method
In our previous study, a 14 min linear gradient from 100% buffer A (2 M
(NH4)2SO4 solution dissolved in PBS, pH = 7.4) to 100% buffer B (40% v/v ACN in
PBS), pH = 7.4) was applied with a mobile phase flow rate of 0.5 mL min-1, where the
ACN worked as an additive.27 However, in comparison to acetonitrile, glycerol was
believed to be more friendly towards EVs retaining their physical structure, and indeed
bioactivity.
Thus, two isolation methods with glycerol as additive were used and compared:
Linear gradient: The column was equilibrated with buffer A (1.8 M (NH4)2SO4
solution dissolved in PBS, pH = 7.4), which also served as the loading medium. Buffer B
(40% v/v ACN in PBS, pH = 7.4) was used as the chromatographic elution solvent as
described previously,25 A 14-min gradient from 100% buffer A to 100% buffer B was
applied at a mobile phase flow rate of 0.5 mL min-1.
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Step gradient: The column was equilibrated with 2 M (NH4)2SO4 solution dissolved
in PBS, pH = 7.4, which also serves as the loading medium. Two gradient steps were
employed, the first consisting of 25% glycerol with 1M (NH4)2SO4 initiated 3 min
following injection and the 50% glycerol in PBS initiated 5 min after the injection. In the
baseline case, separations were performed with a mobile phase flow rate of 0.5 mL min-1.
Liquid chromatography quantification method
UV absorbance at 216 nm was monitored as a means of detecting the eluted species
(small molecules, proteins and EVs). The gradient baseline absorbance was obtained by
running the gradient with no sample injection and was subtracted from the EV separation
chromatograms. Based on the detector response reflecting their elution, purified EVs were
collected using the R1 fraction collector. The peak areas of the elution peaks were
integrated and calculated through the Chromeleon 7 software system. The same isolation
procedure was also performed on the exosome standards dissolved in PBS with different
concentrations to generate response curves, with the quantification of exosomes in the cell
culture milieu sample calculated based on the response functions.
Dynamic binding capacity and exosome recovery
The dynamic binding capacity (DBC) of a chromatography column describes the
maximum amount of target solute that can be loaded onto the column without causing
unnecessary loss, measured under experimental conditions typical for that process.45 Most
commonly, DBCs are determined through the use of frontal analysis (i.e., breakthrough
curves).46,47 In the case of C-CP fiber columns, the two primary factors affecting the kinetic
attributes of the DBC are the solute loading flow rate and column length.48-50 However, in
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this case, the loading sample is cell culture milieu which is not pure EVs, and so the
continuous presence of background species (small molecules, proteins, etc.) which are not
retained, yet also absorb at the monitoring wavelength, makes a direct breakthrough curve
unfit for use. Here, a recovery-based approach to load characterization is employed,
wherein successively larger volumes (constant concentration) of D. discoideum milieu
supernatant are injected onto the column, with the fraction of solutes retained and then
recovered, quantified. Load/elution data were obtained under buffer conditions of 25%
glycerol and 1 M (NH4)2SO4 in PBS; conditions in which the EVs are retained on the fiber
columns, yet other solutes are not. In this method, solutes exceeding the DBC would yield
a capacity-limited recovery. The 5 min load step (much longer than the injection plug) was
followed by EV elution under 50% glycerol in PBS and the absorbance of the elution
transient recorded. For the initial evaluations, the mobile phase flow rates were kept at 0.5
mL min-1 with the column lengths of 5, 10, 20, and 30-cm. The effects of the loading
solvent flow rate on EV DBC were investigated by injecting various sample volumes under
the above loading solvent compositions through a 30 cm long column at 0.2, 0.3, 0.4 and
0.5 mL min-1(equating to linear velocities of 16 - 40 mm s-1) and eluted at 0.5 mL min-1.
The methodologies for evaluating the chromatographic data have been described
previously.48,51
Transmission electron microscopy (TEM)
TEM imaging was used to verify the physical size and structural regularity of
single vesicles and performed according to our previous study.25 The HIC-method-eluted
EVs were negatively stained:52 3.5 μL of sample was placed on a carbon grid and allowed
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to rest for 5 min before blotting with filter paper. Using forceps, the carbon grid was dipped
face down on a 10 μL-water droplet for 2–3 s and again blotted. Two percent uranyl acetate
(3.5 μL) was pipetted onto the grid and allowed to rest for 20 s before blotting and drying.
All TEM images were obtained using a Hitachi HT7830 TEM (Hitachi, Tokyo, Japan) in
the Clemson University Electron Microscopy Facility.
3.4 Results and discussion
Isolation and characterization of extracellular vesicles
In our previous work, acetonitrile was used as additive in the linear-gradient HIC
method on PET C-CP fibers, which provided an efficient way to isolate EVs.25 However,
there was concern that the presence of acetonitrile might cause either damage or
aggregation of the EVs. Given that glycerol is a mild mobile phase modifier in HIC
methods and works as a cryoprotectant for the long-term storage of organisms,36,53 a new
HIC method was investigated with glycerol as the mobile phase modifier. Fig. 3.1 depicts
representative chromatograms of the urinary exosome standard prepared in PBS along with
a solution composed solely of lysozyme, used as a representative of protein elution
characteristics. In the first case, a conventional linear gradient (as employed in the previous
works25) is depicted in Fig. 3.1a. The very intense absorbance in first minutes reflects the
injection peak, with the elution of non-retained species such as salts and assorted small
molecules. The broad, low-response feature between 10 and 15 minutes represents nonpolar molecules or proteinaceous materials, such as reflected in the well-behaved transient
for lysozyme. Subsequently, there is a low-response peak between 17 and 19 minutes; as
anticipated for EVs. It is interesting to note that all proteins and other impurities were
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eluted before the 50% buffer B (equivalent to 25% glycerol) composition, while the
standard exosomes elute as a band at closer to 100% buffer B; 50% glycerol in PBS and
no (NH4)2SO4 present. It is clear that the quality of the chromatogram in Fig. 3.1a is not
of the quality obtained previously for a linear gradient where acetonitrile is used as the
organic modifier.25

Fig. 3.1 Hydrophobic interaction chromatography (HIC) chromatograms of urinary exosome
standard and lysozyme isolation with two gradient modalities methods. a) 14 min gradient from
100% Buffer A (2 M (NH4)2SO4 dissolved in phosphate buffered saline [PBS]) to 100% buffer B
(50% glycerol [vol/vol] dissolved in PBS). b) Two-step gradient of 25% glycerol (3 min) with 1 M
(NH4)2SO4 and 50% glycerol (5 min). Separations were performed with a mobile phase flow rate
of 0.5 ml min-1. Injection volumes = 20 μl, exosome standard concentration = 1.45 × 1013 particles
mL-1, lysozyme concentration = 2 mg ml-1

Based on the large difference in elution solvent composition for the proteinaceous
and target standard exosomes seen in Fig. 3.1a, a step gradient was investigated to shorten
the elution time and simplify the elution procedure, as depicted graphically in Fig. 3.1b.
Seen clearly in the chromatogram, the salts and small molecules elute (un-retained) in the
high-salt injection phase, with proteins and other non-polar molecules eluting with the first
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gradient step (25% glycerol: 1M (NH4)2SO4), and the standard exosomes eluting with the
step to 100 %B (50% glycerol in PBS) composition. As a point of comparison, the
chromatogram of lysozyme shows that the step gradient works efficiently, with all of the
lysozyme eluting in the first step. In comparison to the linear gradient (Fig. 3.1a), the step
gradient not only shortens the overall processing time, but also sharpens the elution bands
to yield better resolution and indeed recoveries; indeed better than the previous works.25
As such, it was determined to proceed with developing the step-gradient methodology.

Fig. 3.2 Transmission electron microscopy (TEM) images of hydrophobic interaction
chromatography (HIC)-eluted standard exosomes obtained using different mobile phase modifiers.
a) 40% acetonitrile. b) 50% glycerol

Transmission electron microscopy (TEM) is a versatile tool in EV characterization,
providing morphology and size information of the vesicles. TEM images where obtained
for of the eluted EVs from a D. discoideum milieu supernatant for the cases of the two
mobile phase modifiers, acetonitrile and glycerol. Figure 3.2a presents a representative
TEM micrograph of the population collected post-column following elution using the
former acetonitrile-solvent process,25

reflecting the expected structure of the D.

discoideum extracellular vesicles. This serves as an indication that the prior method was
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not deleterious to the vesicle structure as may have been predicted.

Likewise, a

representative micrograph for EV isolates using the current HIC method is shown in Fig.
3.2b. The captured-then-eluted EVs in both cases are intact and dispersed, suggesting that
both are viable methods, though the chromatographic yield is higher, and potential for illeffects lesser, for the glycerol-based elution solvent. It is interesting to note that, while the
micrographs are on different size scales, the glycerol-eluted vesicles are ~20% larger than
the acetonitrile case. Working as a cryoprotectant agent, when added to the solution,
glycerol freely penetrates across membranes the membrane and protects EVs from
shrinking.54 Ultimately, the glycerol-assisted HIC method is both efficient at eluting the
EVs from the column and likely more suitable for the overall stability of the EVs.
Quantification of exosomes in D. discoideum supernatant sample

Fig. 3.3 Response curve of a commercial human urine-derived exosome standard prepared at
different concentrations (in a range of 3.62 × 1011–7.25 × 1012 exosomes mL-1) with 20 μL injection
volume, plotted as a function of the number of exosomes injected on-column. Triplicate injections
were performed for each sample volume
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Previous reports demonstrated that the integrated peak absorbance (i.e., scattering)
from the elution band is proportional to the quantity of the isolated EVs,25,27 therefore, the
EVs can be quantified utilizing classic response curves. Different concentrations of the
commercial exosome standard (in a range of 3.62 x 1011 - 7.25 x 1012 exosomes mL-1) with
the same volume (20 μL) were loaded onto the column and eluted using the step gradient
elution program described above.
The data and regression statistics are presented in Fig. 3.3, in terms of the standard
exosome numbers and the integrated absorbance yields. The agreement with linearity (R2
= 0.9991) covers a range of 7.25 x 109 - 1.45 x 1011 standard exosomes injected on-column.
To determine the concentration of EVs in the D. discoideum milieu test sample, 5 μL of
the supernatant was loaded and isolated using the described method, yielding an average
integrated absorbance of 8.45 +/- 0.12 mAU*min, representing an on-column EV loading
of 1.08 x 1011, thus the bulk concentration of EVs in the D. discoideum milieu supernatant
was 2.16 x 1013 mL-1. This value is in line with previous determinations via absorbance
and nanoparticle tracking analysis of this cell line. We note as well the reproducibility to
which these determinations can be made, with triplicates of 5 μL injections showing
precision of 1.4 %RSD.
Optimization Extracellular Vesicle Loading Buffer Composition
The choice of loading buffer composition in any sort of solid phase isolation is
based on finding thermodynamic and kinetic conditions under which the solute is retained
on the phase exclusively in preference to being solvated. In the case of EV isolation from
cell culture milieu, the desired situation is loading under conditions wherein the undesired
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species (i.e., salts, sugars, proteins, etc.) pass through the column unretained, while target
EVs are first retained on the solid phase and then preferentially eluted from it. This is done
not only to obtain high product (EV) purity, but also to provide the maximum amount of
solid phase surface area possible to affect the EV loading, as adsorption of latent proteins
limits the EV binding capacity. To evaluate the ability to solely retain EVs, different
loading (injection) buffer concentrations (from 10% glycerol to 25% glycerol with the
balance of 1 M (NH4)2SO4) and PBS) were evaluated for the isolation of D. discoideum
EVs. In this particular case, for the sake of clarity in the product chromatograms, the
supernatant was first subjected to one round of ultracentrifugation to remove the
background salts, etc. from the injection peak response.

Fig. 3.4 Hydrophobic interaction chromatography (HIC) chromatograms of (a) extracellular
vesicles (EVs) preprocessed by ultracentrifugation and (b) lysozyme (as a protein surrogate)
isolated in the use of different loading buffer (glycerol) concentrations. Two-step gradient of 25%
glycerol (3 min) with 1 M (NH4)2SO4 and 50% glycerol (5 min) was used. Mobile phase flow rate
= 0.5 ml min-1. Injection volume = 20 μL
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As shown in Fig. 3.4a, there is a marked change in the chromatogram makeup as
the loading buffer glycerol content is increased, from 10% to 25%. Specifically, at the
lower glycerol concentrations, there is a clear elution peak in the 3.5 – 5.5 min time frame,
which is attributed to proteinaceous material. This band is not present when loading at 20
and 25% glycerol, suggesting that these species are not retained on the column. At the
same time, the recovery of the EVs remains largely unchanged. The assignment of the
earlier band as represented host cell proteins is validated in Fig. 3.4b, wherein only
lysozyme (20 µL, 2 mg mL-1) was injected onto the column. Visually, these results suggest
that the proteins were eluted in the injection volume without affecting the EV
retention/elution. In fact, the absorbance values for the injection peaks in both sets of
experiments increase appreciably (though not quantitatively with values of >3 AU) when
moving from the 20 and 25% glycerol cases. Thus, a 25% glycerol and 1 M ammonium
sulfate loading buffer composition was chosen as the optimum for subsequent DBC
determinations, as the proteins and other non-polar molecules are passed unretained, while
the EVs are retained on the PET C-CP fiber column. It is important to note that use of this
sort of protocol can reduce the entire isolation/purification program to less than 5 mins.
Effect of C-CP Fiber Column Length on Extracellular Vesicle Processing Capacity
The capacity of the EV isolation and purification process is a combination of the
available fiber surface area and the kinetics of the adsorption process (i.e. column residence
time). To investigate the effect of the fiber surface area on the binding capacity, the length
of the PET C-CP fiber columns was varied (keeping the diameter the same so as not to
change the hydrodynamics). Different volumes of D. discoideum milieu supernatant with
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constant concentration of EVs (1.08 x 1013 mL-1) in buffer (25% glycerol, 1M (NH4)2SO4
in PBS) were injected onto columns of 5, 10, 20, and 30 cm lengths, at a flow rate of 0.5
mL min-1 using the mobile phase composition wherein proteins and non-polar molecules
passed through the column.

Fig. 3.5 Effect of extracellular vesicle (EV) loading volume on the recovered solute response as a
function of capillary-channeled polymer (C-CP) fiber column lengths. Load and elution mobile
phase flow rate = 0.5 ml min-1

Upon completion of the loading step, adsorbed EVs were subsequently desorbed
using a step function increase in solvent B to the normal elution composition of 50%
glycerol in PBS at a flow rate of 0.5 mL min-1. Figure 3.5 presents the integrated
absorbance values for each of the load volumes for the various columns. Use of the elution
signal as a measure of capacity presents a more comprehensive view of the entirety of the
load/elution process. For each of the column lengths, the absorbance signal for the
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recovered EVs increases with the applied volume, to the point where plateauing of the
responses is seen, reflective of column saturation.
Table 3.1 presents the quantitative figures of merit of the experiments. Taking the
20-cm column data as an example, increases in the loading volume are paralleled with
larger elution absorbance responses at 216 nm, up to the point of the 400 μL injection.

Table 3.1 Loading capacities for D. discoideum milieu for different C-CP fiber column lengths.
Solution concentration = 1.08 × 1013 particles ml-1. (n = 3 replicates for each column lengths)
Column
length
(cm)

Saturated
loading
volume
(μL)

Number of loaded
EVs
(x1011particles)
(based on volume)

Elution peak
area
at saturation
(mAU x min)

Number of eluted
EVs (x 1011 particles)
(based on peak area)

Recovery of
exosomes
(%)

5

100

10.8

45.0

5.75

53.2

10

200

21.6

77.6

9.90

45.8

20

400

43.2

177.4

22.63

52.4

30

600

64.8

290.8

37.10

57.2

Beyond this point, the larger injection volume does not yield greater recovery.
Based simply on the relationship between the EV solution composition and the injection
volume, a load value of 4.3 x 1012 particles can be assumed. However, as presented in
Table 3.1, the actual recovery based on an integrated absorbance 177.4 mAU*min and the
calibration function (Fig. 3.3) yields a recovery of 2.26 x 1012 vesicles. The percentage
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recovery of the EVs was calculated for each column length as the fraction of the number
of EVs eluted (NElute) versus the number applied on-column (NLoad):
Recovery = NElute/NLoad X100%

(1)

For the specific case of the 20-cm column, this value is 52.4%.
A comparison of the elution responses for the different length columns of Fig. 3.5
and the tabulate values in Table 3.1, provides a clear picture of the effects of column length.
In the cases of the load volumes/numbers and the recovered absorbances/numbers, there is
virtually a 1:1 increase in capacity as a function of increasing length. In every case of
different column length, the determined number of eluted EVs across the triplicate
experiments were in agreement to better than 4.66% RSD.

In addition, the percentage

recoveries are fairly uniform, with the majority over 50%. This is a key advantage of the
C-CP fiber HIC isolation method, where the typical values for the ultracentrifucation
method are less than 5%.2 Thus, the method has the ability to deliver highly purified EVs
(based on the chromatographic data) with 10X higher recoveries; under these load/elution
conditions.
Effect of Sample Loading Flow rate on Extracellular Vesicle Processing Capacity
To assess the kinetic attributes of the EV isolation process, D. discoideum milieu
supernatant with a constant concentration of EVs (1.08 x 1013 mL-1) in buffer A (25%
glycerol, 1M (NH4)2SO4 in PBS) was injected onto a 30 cm column at various flowrates
(0.2 – 0.5 mL min−1) (equating to linear velocities of 16 – 40 mm s−1). The fiberimmobilized EVs were then eluted with 50% glycerol in PBS at a flow rate of 0.5 mL min-
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1

. The experimental approach and parameters evaluated were conducted in the same

manner as the previous study of column length.

Fig. 3.6 Effect of extracellular vesicle (EV) loading volume on the recovered solute response as a
function of loading solution flow rate for a 30-cm capillary-channeled polymer (C-CP) fiber
column length. Elution mobile phase flow rate = 0.5 ml min-1

As the highest-capacity loading volume of EVs with a 30 cm column was 0.6 mL
of supernatant (Fig. 3.5), test injection volumes of 0.3, 0.4, 0.5 and 0.6 mL were used to
evaluate the role of loading flow rate. As shown in Fig. 3.6, at the same loading volume,
there is a general inverse relationship between the elution peak areas and the flow rates,
demonstrating that longer residence times are beneficial. In fact, there is little difference
between the responses for the two lowest flow rates, where both reach a plateau in EV
recovery at the point of the 500 μL injection volume. Neither of the faster flow rates
reaches a plateau in the amount recovered up to the maximum value of 600 μL, i.e., the
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columns are never saturated. This general response is not unexpected in terms of the
capture of the relatively massive, and slowly-diffusing, EVs, as they must be transported
to the fiber surface to affect adsorption on the time scale of the column transit time.
In the case of the highest linear velocity, this would be <10 s. The responses
depicted in Fig. 3.6, while predictable, are opposite of what are seen in the case of protein
separations on C-CP fiber columns, where linear velocities of up to 100 mm s-1 can be
applied without loss in binding capacity.48,49 The results of the studies of load flow rate on
binding and elution characteristics are presented in Table 3.2. (As a point of reference, the
characteristics for the highest flow rate are the same as those depicted in Table 3.1, taken
under constant flow conditions.) Clearly seen is the role of the loading conditions in
affecting greater overall EV recoveries.
Table 3.2 Loading capacities for D. discoideum milieu for different loading flow rates. Solution
concentration = 1.08 × 1013 particles ml-1. (n = 3 replicates for each flow rate)
Loading
flow rate
(ml/min)

Saturated
loading
volume
(μL)

Number of loaded
EVs
(x1011particles)
(based on volume)

Elution peak
area
at saturation
(mAU x min)

Number of eluted
EVs (x 1011 particles)
(based on peak area)

Recovery of
exosomes
(%)

0.2

500

54.0

354.9

45.3

83.8

0.3

500

54.0

352.4

44.9

83.2

0.4

600

64.8

341.4

43.5

67.2

0.5

600

64.8

290.8

37.1

57.2

The EV recoveries increase dramatically from 57.25% to 83.83% as the loading
flow rate is decreased from 0.5 mL min-1 to 0.3 mL min-1. There are two primary reasons
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for the improved recoveries. First, at lower flow rates, the EVs have more time to bind to
the fiber surface (kinetics), which is reflected in the smaller saturation volumes. In
practice, this lowers the denominator (NLoad) in Eq. 1. In reality, that volume is likely
overestimated as the plateau in response may occur at lower injection volumes based on
the limited sizes of the injection loops employed. Second, the lower flow rates provide
more time for proteins, etc. in the supernatant to clear the column, where they may
potentially compete with the EVs for surface area, thus increasing the amount recovered
(NElute). Ultimately, the highest loading capacity of EVs is 5.4 x 1012 EVs on a 30 cm CCP fiber column, and is achieved when loading at 0.2 mL min-1 and eluting at 0.5 mL min1

, resulting

in an 83.8% EV recovery efficiency in a processing time of less than 5 min. As

noted above, given the large gap in the load injection volumes, this number is likely an
underestimation.
3.5 Conclusions
A glycerol-assisted step gradient HIC method for EV isolation from cellular milieu
media has been developed and characterized. The use of novel PET C-CP fibers in a
microbore column format allows for rapid processing and purification on time scales of 5
– 10 min. Use of the glycerol modifier and processing under neutral pH conditions not
only helps to maintain the structural integrity, but the biological activity as well as shown
in parallel studies, of the isolated EVs. Uniquely, the procedure provides purification and
quantification in a single operation, with the HIC chromatographic method and simple
absorbance detection affected on a standard HPLC platform. The optimized method yields
very high EV purity, as proteins and media components are either eluted prior to the target
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vesicles or are not retained on the column at all. Binding capacities on the order of 1012
EVs, in time frames of a few minutes, with efficiencies of >80% represent a step-function
improvement in EV processing technologies. Based on the results of this study, the
affordability, high throughtput and efficiency of isolation and quantification of EVs in cell
culture milieu samples can be significantly improved, and the new method can be
potentially adopted to applications in clinical and fundamental biochemistry. In addition,
the comparable low cost (< $15) of the column and the rapid separation (< 10 min), as well
as the loading capacity is proportional to the column length, where longer column could
lead to larger loading capacity, make it possible to scale up the exosome isolation. This
method could fulfill the broad spectrum of needs in terms of EVs isolation, from very
generic with relatively high volumes and throughput to highly specific capture on clinical
size and time scales and process scale-up to harvest the large quantities necessary for drug
delivery developments are readily envisioned.
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CHAPTER IV
RAPID SEPARATION OF BLOOD PLASMA EXOSOMES FROM LOW-DENSITY
LIPOPROTEINS VIA A HYDROPHOBIC INTERACTION CHROMATOGRAPHY
METHOD ON A POLYESTER CAPILLARY-CHANNELED POLYMER FIBER
PHASE
4.1 Abstract
Exosomes are membrane-bound, cell-secreted vesicles, with sizes ranging from 30
to 150 nm. Exosomes in blood plasma have become proposed targets as measurable
indicators of disease conditions. Current methods for plasma-based exosome isolation are
time-consuming, complex, and have high operational costs. One of the most commonly
reported shortcomings of current isolation protocols is the co-extraction of lipoproteins
(e.g. low-density lipoproteins, LDLs) with the target exosomes. This report describes the
use of a rapid, single-operation hydrophobic interaction chromatography (HIC) procedure
on a polyester (PET) capillary-channeled polymer (C-CP) fiber column, demonstrating the
ability to efficiently purify exosomes. The method has previously been demonstrated for
isolation of exosomes from diverse biological matrices, but questions were raised about the
potential co-elution of LDLs. In the method described herein, a step-gradient procedure
sequentially elutes spiked lipoproteins and blood plasma-originating exosomes in 10
minutes, with the LDLs excluded from the desired exosome fraction. Mass spectrometry
(MS) was used to characterize an impurity in the primary LDL material, identifying the
presence of exosomal material. Transmission electron microscopy (TEM) and an enzymelinked immunosorbent assay (ELISA) were used to identify the various elution
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components. The method serves both as a rapid means of high purity exosome isolation
as well as a screening tool for the purity of LDL samples with respect to extracellular
vesicles.
4.2 Introduction
Exosomes are a subset of the family of extracellular vesicles (30-150 nm) that
contain nucleic acids, proteins, and other biomolecular compounds from their cells of
origin. Exosome-focused analyses have gained attention and importance in the past two
decades because they can provide detailed insights into physiological interactions

1-3

.

Exosomes mediate a variety of biological functions including intercellular communication,
transport of disease biomarkers and signaling proteins

4-6

, and hold promise as potential

drug delivery vehicles 7-9. One of the most utilitarian aspects of exosomes is their existence
in almost all body fluids; e.g. blood, urine, breast milk, and saliva

1-3

. With regards to

blood plasma, typical densities for healthy individuals are quoted to be in the range of 109
- 1011 particles per mL plasma 10-12; likely a function of the isolation methodology. Recent
studies have shown that differences in the concentration and composition of exosomes in
human blood plasma are associated with various physiological and pathological conditions
13-15

. Therefore, monitoring of the concentration of exosomes in blood, in and of itself,

could be utilized as a measurable indicator of disease presence and progression. Riekkola
et al. have provided a comprehensive review of the methods for the isolation and separation
of extracellular vesicles from diverse media 16.
The high-efficiency isolation and purification of exosomes in blood is a crucial
aspect for the downstream characterization of the analyte, whether for fundamental studies
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or clinical diagnostics. The presence of high densities of proteins, genetic material, and
other bioparticles makes the high-purity isolation of exosomes a genuine challenge. Among
these, evidence shows that a large number (~1x1015 particles mL-1) of low-density
lipoproteins (LDLs), which have been reported as a major risk factor in numerous
cardiovascular diseases 17,18, also exists in human plasma 19. As LDLs and exosomes are
similar in size and density, exosome isolation from blood plasma without the co-isolation
of LDLs is extremely challenging, but necessary as the presence of LDLs could affect the
detection and characterization of the exosomes, leading to an inaccurate understanding
about their number, composition, and biological functions 20,21. Buzás and co-workers have
presented an excellent review on this topic

21

. The most popular method for exosome

isolation from diverse matrices is ultracentrifugation, a process that in itself may damage
exosomes and lead to aggregation 22. Most notably, the process is also susceptible to coisolation of impurities as it is unable to remove extravesicular protein aggregates and LDLs
from exosomal fractions 20,21. To be clear, for the same reasons it is very difficult to purify
LDLs from EVs and the like.
Size exclusion chromatography (SEC)
density gradient ultracentrifugation

27

23,24

, ultrafiltration 25, precipitation 26, and

have been used to isolate exosomes from blood

plasma. However, none of these methods is effective in the removal of LDLs from exosome
populations. Using these methods, it has been reported that over 70% of the particles
isolated from plasma are non-EVs, with LDLs being the main source of contamination
26,28,29

. Karimi et al. reported that a high concentration of LDLs was found in eluted

exosomes isolated by SEC, which was additionally confirmed by Western blot and mass
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spectrometry analyses 30. In addition to their physicochemical similarities, a complicating
factor is the surface adsorption of LDLs onto the target exosomes 20,21. Using transmission
electron microscopy (TEM), Buzás et al. demonstrated that LDLs bond extensively on the
surface of isolated exosomes 21. As the LDLs are reported to be capable of attaching to
hydrophobic surfaces 31, they also tend to adsorb on exosome surfaces by interacting with
hydrophobic regions caused by the lipid packing defects of the exosomal phospholipid
bilayer structure 32. This phenomenon was verified by incubation of isolated exosomes with
commercial LDLs resulting in LDL-associated exosomes 21. Indeed, these associations are
fundamental, and indeed chemically informative, the primary challenge is to isolate the
“free” LDLs from exosomes in the same matrix 20,33.
In addition to size-based methods, other separation modalities have been utilized
for exosome isolation. One example is gradient ultracentrifugation, where isolation is
based on the density of particles. The density of LDLs lies between 1.02-1.06 g mL-1 34,
while the density of exosomes ranges from 1.08-1.21 g mL-1

2,20

. Though the density of

LDLs is slightly lower than exosomes, the difference is generally insufficient to overcome
the resolution limits of the applied density gradient, thus leading to significant
contamination of free LDLs in exosomal fractions. To overcome these deficiencies, most
isolation efforts utilize combinations of different orthogonal separation methods. For
example, Buzás, et al. used differential ultracentrifugation in combination with an SEC
purification step; however, results showed that LDLs were still present in the exosomes
after purification

21

. Vergauwen, et al. removed LDLs from exosomes using a complex

method, including ultrafiltration, density gradient, ultracentrifugation, and SEC
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35

.

Although this method removed LDLs from exosomes, it should be noted that multiple
steps, especially ultrafiltration, are associated with significant losses of the target material,
and large volumes of plasma samples were required for purification

36

. In addition, the

process requires significant effort and overhead costs, limiting feasibility of the purification
scheme. As such, further research into alternative separation methods is necessary to
overcome the challenge of LDL contamination in exosome isolates and their usefulness in
important biological analyses.
Beyond the practically inconsequential density and size differences between
exosomes and LDLs, they do have different physicochemical properties that may be
exploitable for separation purposes. The surface of an LDL particle is surrounded by a
single-layer, hydrophilic membrane consisting of phospholipids, free cholesterol, and
apolipoproteins37, while the outer membrane of an exosome is a phospholipid bilayer that
is more hydrophobic in nature 38. Thus, there would seem to be opportunities to separate
exosomes from LDLs based on their hydrophobicity differences. Recently, Marcus and coworkers developed a method to isolate and quantify exosomes from various fluids such as
cell culture milieu 39, human urine 39,40, and human blood plasma 41 in a single step using
a hydrophobic interaction chromatography (HIC) method on poly(ethylene terephthalate)
(PET) capillary-channeled polymer (C-CP) fiber columns. In the most effective
implementation, a step gradient HIC method is performed employing glycerol as a
modifier, with the entire elution procedure completed in 8 min 41. Efforts have begun in
the characterization of the approach as a high-throughput, preparative method of exosome
purification 42. Likewise, a versatile spin-down approach is being developed for processing
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on clinically-relevant size, complexity, and cost scales 43. It is important to note that the
physical morphology and biological function of the eluted exosomes are preserved when
this methodology is employed; a significant advantage over the more common
aforementioned approaches. Very recently, collaborative efforts between the University of
Michigan and Clemson University, involving proteomic profiling by mass spectrometry,
have demonstrated the efficacy of the C-CP fiber method in yielding exosome fraction
virtually devoid of plasma proteins

44

.

This study seeks to expand on previous work and demonstrate the efficiency of the
C-CP method for exosome isolation and purification to the exclusion of contamination by
free LDLs. In this report, we used the HIC method to isolate fluorescently-labeled LDLs
in a mixture with a commercial human plasma-based exosome standard, demonstrating
their successful separation in a single operational step. On-line UV-Vis absorbance and
fluorescence emission detection were used to monitor the separation of the two
components. Furthermore, a minor fraction eluting in a chromatogram of the primary LDL
material within the band width expected of exosomes was characterized via mass
spectrometry and proteomics analysis and found to be exosomal (not LDL) material. We
believe that the HIC method employing the PET C-CP fiber column provides an easy,
efficient, and low-cost method for the isolation of exosomes in human blood plasma
without contamination of problematic free LDLs in the final exosome fraction. Indeed,
LDLs associated with exosomes are readily identified. The fact that only a single unit
operation is performed portends many advantages over current, sequential-step techniques.
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It is believed that the approach described herein holds promise towards the use of exosomes
across a wide breadth of biochemistry and biotechnology fields.
4.3 Material and methods
Chemicals and instrumentation
Ultra-pure grade ammonium sulfate and biotechnology-grade glycerol were
purchased from VWR (Sokon, OH, USA). Phosphate-buffered saline (PBS) (10X) was
purchased from Hyclone Laboratories. Inc. (Logan, Utah, USA) and diluted with ultra-pure
water (18.2 M Ω cm) obtained from a Millipore water system (Billerica, MA, USA).
HPLC-grade acetonitrile (ACN) was purchased from EMD Millipore (Billerica, MA,
USA). Fluorescently-labeled, low-density lipoprotein from human plasma (BODIPY™ FL
LDL) was purchased from Life Technologies (Carlsbad, CA, USA) at a stock solution
concentration of 1 mg mL-1 and diluted with PBS to 0.25 mg mL-1 for further use. Exosome
populations utilized as “standards” were purchased from HansaBioMed Life Sciences
(Tallinn, Estonia). (To be clear, these materials are not certified reference materials.) In
this case, lyophilized exosomes derived from human plasma from “healthy” donors, with
a PBS buffer-suspended mass equivalent concentration of 1.4 x 1012 particles mL-1, were
diluted with PBS to 2.8 x 1011 particles mL-1 for further use. A test mixture of
“contaminated” exosomes was made from the LDL and the exosome standards with a
concentration of 0.25 mg mL-1 and 2.8 x 1011 particles mL-1, respectively in PBS, and
analyzed within minutes of mixing. The assumption, in this case, was that the commercially
sourced LDLs and exosomes, themselves, do not contain the other component. As seen
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here, this was not a correct assumption as the primary LDL sample itself contains remnant
exosomal material.

Fig. 4.1. Diagrammatic representation of the experimental apparatus employed in
lipoprotein/exosome isolation experiments.

The instrumental components of the described studies are depicted in Fig. 4.1. All
chromatographic measurements were performed on a Dionex Ultimate 3000 HPLC system
(LPG-3000 quaternary pump, WPS-3000 Autosampler, MWD-3000 UV–Vis absorbance
detector, and FLD-3000 fluorescence detector; Thermo Fisher Scientific, Sunnyvale, CA,
USA) and controlled by the Chromeleon 6.8 software system. A wavelength of 216 nm
was used post-column for UV-Vis detection, as in the case of a standard HPLC method for
exosome purification 39. While the nanometer-sized vesicles do not technically absorb UV
photons, previous efforts have shown that the amount of light scattering is indeed
proportional to their concentration in solution
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40

. Likewise, the lipoproteins show

appreciable responses at this wavelength. Fluorescence detection of the labeled LDLs was
accomplished using an excitation wavelength (lexc) of 500 nm and detection at the emission
wavelength (lem) of 520 nm, respectively. As is common, the UV and fluorescence gradient
baseline responses were obtained by running the gradients with no sample injection and
were subtracted from the respective analytical chromatograms.
The PET C-CP fiber column manufacturing process has been described in a
previous communication

45

. Briefly, eight rotations of PET fibers (equaling 450 single

fibers) were rinsed with hot water, ACN, isopropanol, and Milli-Q water, then pulled
through a 30-cm polyether-ether-ketone (PEEK) tubing with an inner diameter of 0.76 mm
(IDEX Health & Science LLC, Oak Har-bor, WA, USA). After packing, the column was
washed with Milli-Q water, ACN, and Milli-Q water sequentially, at a flow rate of 0.5 mL
min-1 on the HPLC system until a stable baseline was observed by the UV–VIS absorbance
detector (216 nm). Once assembled and cleaned, the C-CP columns were stored at ambient
conditions. The columns were cut into 5 cm lengths for use in the separation experiments.
HIC liquid chromatography method
The same HIC method previously developed for the isolation of exosomes from
human blood plasma was employed here, addressing questions of the efficacy of those
previous works in isolating exosomes from lipoproteins 41. The column was equilibrated
with 2 M (NH4)2SO4 solution dissolved in PBS, pH = 7.4, which also served as the loading
medium. Two gradient steps were employed, the first consisting of 25% glycerol with 1M
(NH4)2SO4 was initiated at 3 min following the injection, and the second consisting of 50%
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glycerol in PBS was initiated 5 min after the injection. The separations were performed
with a mobile phase flow rate of 0.5 mL min-1.
Mass spectrometry and bioinformatics analysis
The elution mobile phase of the collected LDL fraction (25% glycerol and 1 M
(NH4)2SO4 in PBS) was replaced with PBS and concentrated to about 50 µL using an
Amicon Ultra-4 50kDa regenerated cellulose centrifugal filter at 3,700 x g for 10-15 min
(depending on the volume of residual liquid). The concentrated sample was dried using a
SpeedVac (Labconco, Kansas City, MO), after which the sample was prepared according
to the filter aided sample preparation (FASP) procedure as previously reported

46

. The

tryptic digests of the sample were desalted by homemade C18 tips,47 and then separated on
an EASY-nLC 1000 liquid chromatography system (Thermo Fisher Scientific, San Jose,
CA) with a 250 mm reverse-phase (RP) C18 column. The samples were resolved under a
120 min linear gradient from 2 to 35% acetonitrile in 0.1% formic acid at a constant flow
rate of 300 nL min-1. The samples were analyzed on an Orbitrap Lumos mass spectrometer
(Thermo Fisher Scientific), operated in the positive ion mode. The capillary temperature
and the spray voltage were set at 200 °C and 2.5 kV, respectively. The data were acquired
in a data-dependent mode, where up to 20 of the strongest intensity primary MS peaks were
selected for subsequent MS2 analysis. For every selected peak, collision-induced
dissociation (CID) was performed. The spectra (m/z 350−1650) and the MS2 spectra were
acquired in the Orbitrap and linear ion trap, respectively.
All raw data files were processed by the Proteome Discover computational
proteomics platform (version 1.6.1.0)

48

. The parameters were set as follows: database,

75

human UniProt; enzyme, trypsin; fixed modification, carbamidomethyl (C); variable
modifications, oxidation (M) and protein N-terminal acetylation; up to two missed
cleavages allowed. The MS mass tolerance was set as 20 and 6 ppm for the first search and
main search, respectively; the MS2 mass tolerance was set as 0.5 Da. The false discovery
rates (FDRs) for peptides and proteins were both set as 1%. Gene ontology analysis of all
identified proteins was investigated with FunRich V3.1.3 using the Gene Ontology
Database

49,50

. The Vesiclepedia database search was also performed in the FunRich

software environment 50,51.
Transmission electron microscopy (TEM) characterization
TEM imaging was used to verify the physical size and structural regularity of single
vesicles and lipoproteins performed according to our previous study 39. The HIC‐method‐
eluted EVs were negatively stained 52: A carbon-coated 400-mesh copper grid is floated
onto a 40µl drop of the suspension of the sample submitted. The grid is removed; excess
sample is drained off with the edge of clean filter paper. A trace of Bacitracin is added to
3% aqueous phosphotungstic acid (PTA) after adjusting pH to 6.8-7.0. Bacitracin is used
as a wetting agent, so the PTA is spread evenly across the grid. The grid with sample is
floated onto a drop of 3% PTA for 1 minute. After draining excess stain off grid, the grid
is allowed to dry on filter paper before viewing with the TEM. All TEM images were
obtained using a JEM-1011 TEM (JEOL, Inc., Tokyo, Japan) at the University of Georgia
Electron Microscopy laboratory.
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Enzyme-linked immunosorbent assay (ELISA) analysis
An indirect ELISA analysis was used to compare the response of the exosome and
LDL recoveries using antibodies to the CD81 EV marker (Santa Cruz Biotechnology,
Dallas, TX, 200 µg mL-1) and Apo-B 100 LDL marker (Fisher Scientific, Waltham, MA,
1 mg mL-1) proteins after their elution from the 1 cm C-CP fiber solid-phase extraction
spin down tips using the same elution protocol as the column separations. The spin-down
C-CP tips were created and employed through the method as previously reported using the
HIC mode workflow in a table-top centrifuge 43. For this application, the starting materials
of exosome standards (1:100 in PBS), LDL standards (1:100 in PBS), a mixture of exosome
and LDL standards (1 µL of both exosome and LDL standards in 100 mL of 2M ammonium
sulfate), and human serum diluted 1:1 in 2M ammonium sulfate were applied to the C-CP
tip sample reservoir (200 µL) for capture. The elution of proteins was induced using a
solution of 25% glycerol with 1M ammonium sulfate, and the elution of the concentrated
EVs was induced using 50% glycerol. In preparation for the ELISA application, a 100 kDa
ultrafiltration unit was used to reduce the amount of glycerol remaining in the sample
(known to interfere with antibody binding). The fractions were then diluted in a 1:1 ELISA
coating buffer (0.05 M carbonate-bicarbonate in PBS) and allowed to incubate overnight
at 4ºC to coat the cell well plate with the analytes. Positive controls for exosome, LDL, and
human serum standards were also applied, as well as negative controls of PBS, protein
elution buffer, and EV elution buffer. Each sample type was analyzed in triplicate. After
incubation, the plates were washed with sterile PBS (200 µL per well, 30 minutes, 6 buffer
changes) and blocked with 5% dry milk in PBS at room temperature (30 min) before
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continuing. The wells were incubated with the antibodies to the specific targets: CD81 (1
µg mL-1, 50 µL, mouse) and Apo B 100 (1 µg mL-1, 50 µL, mouse) overnight at 4ºC. The
washing and blocking steps were repeated before applying the goat anti-mouse HRP
conjugated secondary antibody (1:1000, 50 µL, RT, 2 hours). A 30-minute wash step using
200 µL of PBS per well and 6 buffer changes followed the secondary antibody incubation.
Finally, 200 µL of the 1-Step Ultra TMB-ELISA Substrate Solution was applied per well
and incubated at room temperature for 30 minutes. The Synergy H1 microplate reader was
used to measure the absorbance of the colorimetric response resulting from the HRP
catalyzed oxidation of the TMB substrate, correlating with the immune response of the
immobilized analyte. The absorbance measurements for each well were measured in
triplicate.
4.4 Results and discussion
Isolation of exosomes and removal of LDL
In our previous study, the step gradient HIC method with C-CP columns was used
for exosome isolations from different matrices and showed the isolation of the target
exosomes from matrix proteins 41,42. In that method, salts and small polar molecules elute
in the injection volume, with proteins and other macromolecules eluting in the first gradient
step (fraction 1), followed by the lone-remaining exosomes eluting in the second step
(fraction 2).

(The lack of vesicular bodies in the HIC injection volume has been

demonstrated for the case of lentivirus particles, where no genetic material was revealed
via qPCR analysis
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.) It was assumed that any present LDLs were removed along with

the proteins. To unequivocally address this point, the step gradient HIC method based on
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our previous work 41 was used to isolate plasma-based exosomes from deliberately-added
LDLs. To further distinguish the difference between LDLs and exosomes, a fluorescence
detector was used in-line following the standard UV detector to monitor fluorescentlylabeled LDLs and non-tagged exosome standards. The use of the two detectors in tandem
provides dual-detection for the LDLs, while the exosomes only register in the absorbance
channel.

Fig. 4.2. Chromatograms of LDL, plasma-based exosome standard, and LDL+ exosome standard
isolation. a) UV absorbance at 216 nm; b) Fluorescence excitation at 500 nm and emission at 520
nm. Step gradient of 25% glycerol with 1M (NH4)2SO4 (3 min) (fraction 1) and 50% glycerol (5
min) (fraction 2) were performed. Separations were performed with a mobile phase flow rate of 0.5
mL min-1. Injection volume = 40 µL. LDL concentration = 0.25 mg mL-1 and exosome standard
density = 2.9 x 1012 particles mL-1.

Fig. 4.2 depicts representative chromatograms of the three sample cases (LDL and
exosomes individually and the mixture) with monitoring by UV-Vis and fluorescence
detector responses. In Fig. 4.2a, the intense absorbance in the first minute of each of the
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chromatograms reflects the injection peak, which is composed of non-retained species
inclusive of the PBS sample matrix components. Looking first at the chromatogram for the
LDL sample, a large elution band is seen just beyond the point of the first gradient step
(initiating the onset of fraction 1), as seen previously for the protein components in various
test media. There is also a small response seen at a time just beyond the second step
(initiating the onset of fraction 2), the point in the gradient at which exosomes typically
elute. This solute species could indeed be exosomes or lipoprotein aggregates from the
lipoprotein sample (as provided by the supplier) as the retention time is the same as that of
exosomes. Alternatively, this band could be a population of large, very hydrophobic
lipoprotein aggregates. Based on independent absorbance measurement of the same
concentrations prepared from the LDL sample, the relative concentration of LDL-related
species is ~20% that of the first band. For the case of the exosome standard, here again,
there are two peaks corresponding to the two gradient steps, with the band eluting between
6.5 and 7.5 min (corresponding to exosomes) being far more prominent than in the case of
the LDL injection. It should be noted that our previous work demonstrated that the
commercial-sourced exosomes derived from a combination of ultracentrifugation and
microfiltration procedures, still contained proteinaceous impurities

40

.

Finally, the

chromatogram of the 1:1 mixture of the LDL and exosomes displays what would be
expected, as the peak absorbances are a combination of the two solutes in solution. Table
4.1 provides a quantitative summary of the absorbance data for the three chromatograms,
with the results representing the average values for triplicate injections. In each case, the
determined integrated peak areas show a precision of better than 10 %RSD for the
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absorbance measurements. As can be seen, the determined values for the combined sample
do indeed reflect a near linear-combination of the individual ones, as would be anticipated
based on Beer’s Law.
Table 4.1. Absorbance peak areas of the LDL and exosome standard samples for the respective
elution bands (fractions 1 and 2). The data were obtained with a UV absorbance detector at 216
nm. (n=3 replicates for each sample.)
Peak area of
fraction 1
(mAU*min)

%RSD of
fraction 1

Peak area of fraction
2
(mAU*min)

%RSD of
fraction 2

LDL

18.2

8.5

3.7

4.9

Exosome standard

26.2

1.5

16.1

1.6

45.7

2.1

19.1

1.1

41.1

1.5

19. 5

1.8

LDL + exosome
standard
(initial)
LDL + exosome
standard
(1 h incubation)

Buzás et al. have clearly demonstrated that LDLs bind extensively onto exosomes
and other EVs 21,54. Furthermore, they found that incubating isolated EVs with commercial
LDLs for 1 h at room temperature at a concentration characteristic for healthy blood plasma
resulted in a dramatic attachment of LDLs to the vesicles 21.

The final row of the Table

4.1 reflects the case where the mixture solution was allowed to sit in ambient conditions
for ~1 hr prior to injection. This rudimentary test was performed here akin to Buzás, that
the LDLs might adsorb to the surface of the exosomes, perhaps providing initial insights
to in vitro processes. While the loss of free LDL is suggested in the ~10% absorbance
decrease in the first elution peak (fraction 1), the absorbance for the second elution band

81

(fraction 2), while slightly increased, are not statistically different from the fresh mixture.
Based on the absorbance results, this process, if occurring, either takes place on longer time
scales or the complex does not add appreciably to the optical density.
As a comparison, Fig. 4.2b presents the equivalent fluorescence detection
chromatograms for the same sample injections as Fig. 4.2a. Because only the LDLs have
a fluorescent tag, only species from those solutions should yield a response. The
chromatograms again display three peaks, corresponding to the unretained species, and the
two gradient steps. The fluorescence detector was in-line following the UV-Vis detector,
with a response (band elution time) delay of approximately 0.5 min. The intense
fluorescence observed in the injection peaks can be attributed to unbound fluorescent tags,
hydrophilic fragments of lipoproteins, unretained LDLs, and components of the PBS
sample solvents. As anticipated, the fluorescence chromatogram for the LDL sample shows
an intense band equating to the position of the first gradient step (fraction 1), but also shows
a small peak corresponding to the second step (fraction 2). As discussed above, these could
either be LDL aggregates or remnant exosomes in the primary material which have been
functionalized or have lipoproteins adsorbed to them. Based on the work of Buzás et al.
the latter seems most likely 21. In fact, the relative populations between the fraction 1 and
2 for the LDL-only separations are ~5:1, and are the same in the absorbance and
fluorescence detection modalities. This point was assessed through proteomics assays as
described in subsequent sections.

The chromatogram for the exosome standard is

structured as expected, with only a small fluorescence response seen in the injection peak
due to components in the PBS matrix and perhaps amino acids and peptides having native
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fluorescence. As would be anticipated given successful isolation, the chromatogram of the
LDL/exosome mixture is virtually indistinguishable from that of the LDL-only sample.
Here again, the temporal behavior suggests that the latter peak likely represents LDLs
adsorbed onto exosomes.

Table 4.2. Fluorescence peak areas of the LDL and exosome standard samples for the respective
elution bands (fractions 1 and 2). The data were obtained with a fluorescence detector with
fluorescence excitation at 500 nm and emission at 520 nm. (n=3 replicates for each sample.)
Peak area of fraction 1 %RSD of fraction
(x 104 counts*min)
1

Peak area of
fraction 2
(x 104 counts*min)

%RSD of
fraction 2

LDL

89.3

0.76

10.7

4.1

Exosome standard

ND

--

ND

--

15.7

2.9

17.5

3.8

LDL + exosome
78.3
1.3
standard (initial)
LDL + exosome
standard
74.2
2.7
(1 h incubation)
ND – Fluorescence not detected above background levels

Table 4.2 presents the quantitative aspects of the fluorescence chromatograms.
Here, the consistency of the separations is confirmed through the precision metrics, with
the majority of the labeled lipoproteins indeed eluting as a well-resolved band distinctive
from the target exosomes.

Here again, as in the absorbance case (Table 4.1), the

fluorescence response suggests that free LDLs are adsorbing to the spiked exosomes. The
fluorescence data from the incubated mixture again seem to suggest some level of LDLexosome adsorption as the fluorescence response in the first peak component indeed
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decreases to the same extent as the absorbance data, with the increase in the exosome
elution band increasing to a more appreciable level. Based on these experiments, it is clear
that free lipoproteins and exosomes have distinctly different chromatographic
characteristics when separated via HIC on PET C-CP fiber columns, with the individual
separations occurring at a very high level of repeatability and a lack of memory effects.
Proteomic characterization of elution bands via mass spectrometry (MS)
The question remains as to the identity of the late-eluting fraction from the primary
LDL sample. Specifically, were these agglomerates of lipoproteins or were they remnant
exosomal material (perhaps with adsorbed lipoproteins) as the chromatography suggested?
To determine the identities of the species making up the collected fraction 2 from the LDLonly injection, and its contents analyzed by mass spectrometry. As shown in Fig. 4.3a, a
total of 123 proteins were identified from the band eluting from the second gradient step,
with most of the proteins identified having been previously reported by Vesiclepedia. To
further characterize the identified proteins, we performed a gene ontology analysis of all
identified proteins. As expected, cellular components for the majority of identifications
were determined to originate from extracellular vesicle exosomes (59.3%), extracellular
regions (36.1%), extracellular space (34.3%), and blood microparticles (25%), as shown in
Fig. 4.3b. Identified proteins were confidently assigned (p-value<0.001) to three molecular
functions: structural constituent of cytoskeleton (11.1%), antigen binding (11.1%) and
immunoglobulin receptor binding (10.2%). These analyses showed that most of the
proteins in the second fraction are exosome/EV-based, and few of them are related to
lipoproteins, which supports the second hypothesis that impurities, such as exosomes, exist
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in the commercial LDL products. This result is consistent with the conclusion in other
studies, where LDLs were still associated with their parent-solution EVs.20,55 These
species are indeed relevant in characterizing exosome populations but are not the free LDLs
which often confound exosome purification.

Fig. 4.3. Bioinformatics analysis. a) Venn diagram showing the overlap of proteins identified in
this study versus the Vesiclepedia database. b) Gene ontology analysis of all identified proteins for
molecular function and components of the LDL sample in fraction 2

To quantify the lipoprotein content in fraction 2 of the primary LDL solution
separation, we employed mass spectrometry analysis as well. Considering that the original
loading sample is a commercial standard LDL sample (theoretically, it does not contain
other lipoproteins particles), Apo B-100 can be used as a marker of LDL. Each LDL
particle contains an Apo B-100 molecule, which accounts for 99% of its total protein mass
37,56

. Therefore, the relative content of LDL within the second elution band can be reflected

by quantifying Apo B-100. Among all apolipoproteins, the mass spectrometry results
showed that only Apo B-100 was identified. Label-free quantification (spectral counting)
was carried out to determine the relative abundance of Apo B-100 within the sample (after
keratin removal), with the results indicating that Apo B-100 accounted for only 0.3% of
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the protein content (279 identified) in the second (exosome) fraction. (Complete assay
available on request.) This value is consistent with previous proteomic profiling of serumderived exosomes isolated using the C-CP HIC method 44. Based on this quantification, it
would appear that the second elution band of the LDL standard is likely composed of both
exosomes which have either incorporated the fluorescent tags and tagged lipoproteins
adsorbed to their surfaces.
TEM characterization of exosomes and LDLs
To complement the chromatographic and MS results presented above, TEM was
used to identify exosomes and LDLs eluted in the course of the step gradient processes.
Fig. 4.4 presents micrographs of fractions collected at different processing steps: preinjection (standards), post-protein elution, and post-exosome elution.

Fig. 4.4. TEM images of the raw LDL and exosome solutions, the mixture, and fractions collect
following the protein elution (fraction 1) and exosome elution (fraction 2) steps. a-c) LDL standard,
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d-f) exosome standard, and g-i) LDL and exosome mixture. In each case, the scale bars represent
a length of 200 nm

Micrographs in Figs. 4.4a-c are images of the commercial LDL standard separation.
In Fig. 4.4a, the image shows most particles having sizes of around 20 nm, while there is
still a population of larger particles (> 50 nm), which we suggest are exosomes based on
the chromatographic results and their appearance. The micrograph following the protein
elution step (fraction 2) (Fig. 4.4b) illustrates the elution of LDLs based on the vesicular
sizes, while the fraction collected from the second elution step (Fig. 4.4c) reveals the
presence of exosomes (~ 90 nm).

The corresponding images for the fractions of the

exosome standard are presented in Figs. 4.4d-f. Here again, a diversity of species forms
and sizes are seen in the primary solution Fig. 4.4d), while small particles were eluted in
fraction 1 (Fig. 4.4e), which are suggested to be LDL or exomere (size < 30 nm) bodies,
with exosomes identified in fraction 2 (Fig. 4.4f). Fig. 4.4g-i illustrate the images for the
mixture of the LDL and exosome standards, following the respective steps. With the
addition of the LDL standard, the exosomes appear to aggregate to some extent, with the
LDLs showing some tendency to attach to the exosome surfaces (Fig. 4.4g). While the
image from the first elution step (Fig. 4.4h) appears to be predominately LDL-sized bodies,
there are still some LDLs attached to exosome surfaces following the exosome elution step
(fraction 2) (Fig. 4.4i). The presence of these species in the different elution fractions
demonstrates that free LDLs and exosomes were eluted in the first and second elution steps,
respectively. However, LDLs can be found in the second elution step if they attached to
exosome surfaces. Likewise, small vesicles, e.g. exomeres (< 30 nm), are likely collected
following the first elution step. While TEM analysis of vesicles is always open to some
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level of interpretation, the results here are consistent with the findings of both the
chromatographic and proteomic assays. Additionally, it must be admitted that the density
of imaged vesicles is less than desirable, due the dilution occurring in the HIC separations.
Higher densities could be achieved via solvent evaporation/filtration prior to deposition on
the TEM grids.
ELISA characterization of exosomes and LDLs
An indirect ELISA assay was used to compare the initial CD81 and Apo B antigen
concentrations of the sample standards, the mixture, and a human serum sample, along with
their respective recoveries in the course of the isolation process using the C-CP tips. In
each case, buffer blanks were run in parallel, with their near-zero responses subtracted from
the analytical determinations. Fig. 4a presents responses towards CD81 (representative of
exosomal material) and Fig. 4b the responses towards Apo B (representative of
lipoproteins). In Fig. 4, “P” represents the ELISA response for the components eluted
under protein elution conditions (25% glycerol with 1M ammonium sulfate, fraction 1),
and elution “E” represents those species eluted under the EV elution conditions (50%
glycerol, fraction 2), respectively for each sample type. The general efficacy of the test
method is reflected in the responses for the starting materials, where the respective
absorbance values for the neat exosome and LDL standards combine to yield the values in
the mixture. Likewise, the obtained precision (as reflected in the error bars) is quite
acceptable.
It is important to note that though the LDL and exosome standards claim to be pure,
both the standard types are co-contaminated with the other vesicle sub-type, as both probe
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targets are highly expressed in their primary stocks and are not alleviated through the
employed purification processes. Often, the concentration of Apo B in an EV recovery
from plasma is regarded as a measure of the EV purity. With the high response of Apo B
from the EV standard, this reflects low purity from the commercial EV source. However,
apolipoprotein proteins (i.e., Apo-B, Apo-E) have been identified in blood-sourced EVs,
indicative of vesicles from melanocyte (pigment cell) mother cells.57 On the other hand,
EVs have also been reported to quickly expose the hydrophobic core of their phospholipid
bilayer membranes to compensate for lipid packing defects 32. allowing for LDLs to attach
to the surface of EVs in these hydrophobic pockets. These interactions cause the
discrimination between LDL contaminants and LDL-associated EVs in the C-CP tip
recovery to be very challenging 21.
The most straightforward means of assessing the vesicle-discrimination
characteristics for the HIC process is to compare the respective CD81 and Apo B responses
for the elution fractions for each sample type. Using the most relevant case of the
LDL/exosome mixture as an example, the responses are instructive. In the case of the
CD81 assay (Fig. 4.5a), it is seen that there is a modest amount of the tetraspanin protein
present in the “protein” elution fraction, but the amount in the “exosome” elution fraction
is many times higher. By the same token, as reflected in Fig. 4.5b, the amount of Apo B
in the “protein” elution fraction is multiple times higher than in the “elution” fraction.
Indeed, the relative ELISA responses for the lipoprotein here mirrored the relative
fluorescent intensities for fractions 1 and 2 for the mixture (Fig. 4.2b) and presented
numerically in Table 4.2. Across all of the sample types, it is always the case that the vast
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majority of the CD81-containing species elute from the C-CP fiber stationary phase under
the EV elution conditions (fraction 2), and the majority of the Apo B containing species
elute under the protein elution conditions (fraction 1).

Fig. 4.5. Indirect ELISA employing antibodies to the EV marker - CD81 (a) and LDL marker Apo-B 100 (b) proteins to confirm the presence of LDLs and EVs in the sample standards, and after
recovery from the C-CP tip using the HIC mode workflow. The elutions were recovered from
protein (P - 25% glycerol, 1M ammonium sulfate) (fraction 1) and EV (E - 50% glycerol) (fraction
2) elution conditions

The result is consistent as well for the human serum test sample. These results
reveal highly preferential isolation of the Apo B-containing species (LDLs) from the
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CD81-containing species (EVs) based on their relative hydrophobicity using the HIC
methodology on the PET C-CP fibers. Based on the ELISA response ratios for the
respective fractions (1 and 2), more than 60% of the LDL particles were removed in the
protein elution step, and more than 75% of the EVs were recovered in the EV elution step.
Of course, there could be the chance where both of the species could have eluted in the
injection volume, but analogous studies of lentivirus particle recovery in that fraction
suggest that this possibility is remote 53.
While the level of preferential isolation shown in Fig. 4.5 is substantial given the
simplicity of the method, and in particular versus more established methods, the ELISA
data certainly reflect a non-ideal separation. For example, response to the CD81 protein is
also observed in the species recovered from species collected under the protein elution
conditions for all of the samples. This could possibly be due to the presence of a subpopulation of ~35 nm exomeres (as suggested in the TEM analysis), eluted during the
protein elution step 58, which would contain the CD81 protein. Given the similarity in size
to LDLs and the vesicles' non-membranous structure, an exomere particle's hydrophobicity
is potentially more similar to that of LDLs than EVs. Alternatively, detecting the CD81
protein in the protein elution step could also indicate the elution of previously-lysed
vesicles under these conditions. By the same token, as stated previously the presence of
LDL species eluted under the exosome elution conditions may indeed reflect lipoproteins
adsorbed to exosomes, thus producing a positive response for Apo B. That said, it must
ultimately be noted that the levels of the measured absorbance for each of the “exosome
elution” fractions in Fig. 4.5b are <5X the level of PBS-blank ELISA measurements.
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Given the sensitivity of ELISA, this suggests very low concentrations of LDL-related
species.
4.5 Conclusions
The co-extraction of free low-density lipoproteins (LDLs) and exosomes has been
a major challenge to an improved understanding and utilization of these important
extracellular vesicles (EVs). Indeed, this is a major complicating aspect in source the
“pure” vesicles. This report demonstrates the isolation of free LDLs from human plasmaderived exosomes using a hydrophobic interaction chromatography (HIC) process in a
single unit operation on a polyester capillary-channeled polymer (C-CP) fiber
chromatography column. The HIC method, employing a two-step gradient, results in
elution of LDLs in a manner very similar to other proteinaceous species, with the target
exosomes subsequently eluting in a well-defined band. The entire procedure is completed
in less than 10 minutes on sample volumes of <50µL, though the process could be readily
upgraded to the mL scale. Subjecting the primary LDL material to the separation protocol
revealed a fraction of that population (perhaps 20%) that elutes in the same bandwidth as
exosomes. Not surprisingly, detailed mass spectrometry-based proteomics analysis of that
fraction revealed the existence of exosomal material in the primary LDL material. Thus,
the method also proves to be an effective means of rapidly assessing the purity of those
materials. Mixing of the LDL specimen with the human plasma exosome standard
confirmed the solution-phase adsorption of a small amount of the lipoproteins to the
microvesicles, as would be expected based on prior works. TEM and ELISA results
demonstrated that LDL and exosomes were isolated in the first and second steps,
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respectively. The combination of the proteomics and bioassay results suggest very high
levels of purity of the exosome fraction in comparison to other physical separation
methods. The ability to chromatographically-resolve exosomes from problematic freeLDLs in solution, along with the versatility of the C-CP fiber platform (either in column
or spin-down tip format) to rapidly process diverse biomedia, is expected to have an impact
in fundamental biochemical studies and clinical chemistry applications related to
extracellular vesicles.
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CHAPTER V
RAPID ISOLATION OF LENTIVIRUS PARTICLES FROM CELL CULTURE
MEDIA VIA A HYDROPHOBIC INTERACTION CHROMATOGRAPHY METHOD
ON A POLYESTER, CAPILLARY-CHANNELED POLYMER FIBER STATIONARY
PHASE
5.1 Abstract
Lentiviruses are increasingly used as gene delivery vehicles for vaccines and
immunotherapies. However, the purification of clinical-grade lentivirus vectors for
therapeutic use is still troublesome and limits preclinical and clinical experiments. Current
purification methods such as ultracentrifugation and ultrafiltration are time consuming and
do not remove all of the impurities such as cellular debris, membrane fragments, and
denatured proteins from the lentiviruses. The same challenges exist in terms of their
analytical characterization. Presented here is the novel demonstration of the
chromatographic isolation of virus particles from culture media based on the
hydrophobicity characteristics of the vesicles. A method was developed to isolate lentivirus
from media using a hydrophobic interaction chromatography (HIC) method performed on
a polyester, capillary-channeled polymer (PET C-CP) stationary phase and a standard
liquid chromatography apparatus. The method is an extension of the approach developed
in this laboratory for the isolation of extracellular vesicles (EVs). Quantitative polymerase
chain reaction (qPCR) was used to verify and quantify lentiviruses in elution fractions.
Load and elution mobile phase compositions were optimized to affect high efficiency and
throughput. The process has been visualized via scanning electron microscopy (SEM) of
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the fiber surfaces following media injection, the elution of proteinaceous material and the
elution of lentiviruses. This effort has yielded a rapid (<10 min), low cost (< $15 per
column, providing multiple separations), and efficient method for the isolation/purification
of lentivirus particles from cell culture media at the analytical scale.
5.2 Introduction
Lentivirus is a genus of retroviruses having a size range of 80–100 nm in diameter.
Lentivirus-based vectors can transduce a wide range of cell types and integrate into the
host genome, providing long-term gene expression of the transgene both in vitro and in
vivo

1,2

. Thus, lentivirus is a promising tool for vaccination 3-5, gene therapy 6, and cancer

immunotherapy

7,8

. Lentivirus is one of a number of vesicular-structured bio-nanobodies

being developed in the gene therapy arena 9,10. Along with the increasing use of lentiviral
vectors, the demands for highly efficient purification procedures with improved process
safety and throughput
Ultracentrifugation

12

for the generation of these vectors are also increasing

and ultrafiltration

13

1,11

.

, the most common techniques for lentivirus

purification, would be best termed “physical” isolation approaches as the size/density of
the particles is the primary means of separation from other culture constituents. However,
these methods generally require longer processing times (> 3 h), with post-isolation assays
typically revealing the presence of residual cellular debris, membrane fragments, and the
denatured proteins derived from the culture media

14

. These impurities may be toxic to

lentivirus-treated cells, particularly primary cells, reducing transduction efficiencies, and
potentially causing immunogenic reactions in experimental animal models and the human

101

body 15,16. The challenges here are equally relevant for small-scale quantities employed for
fundamental research and the production scale.
Other separation methods for lentivirus purification include ion-exchange
chromatography (IEC) 14, affinity chromatography 17, size exclusion chromatography 18,
and sucrose gradient centrifugation 19. Unfortunately, these methods can require complex
protocols, specialized equipment, and expensive materials/chemicals, and are inefficient
with regards to the yields and purity of the lentivirus products. The challenges as they
relate to standard porous bead chromatographic media used in IEC emanate from the
combination of the large physical size of the particles (~100nm; creating poor mass transfer
characteristics and limiting surface interaction) and the chemically-complex nature of their
membrane envelope surfaces. As presented by Jungbauer et. al

20,21

, such vesicular

modalities call for the consideration of different chromatographic phase formats.
Ultimately, a simple and low-cost purification method for lentivirus recovery is desired to
reduce the carryover of potentially toxic culture by-products and increase processing
reliability.
The Marcus and Bruce groups have successfully employed capillary-channeled
polymer (C-CP) fibers within a hydrophobic interaction chromatography (HIC) method to
isolate and purify EVs based on their hydrophobicity differences while still maintaining
their structural integrity and biological activity 22-25. Exosomes are a class of EVs that are
50-130 nm in diameter and are of interest due to their roles in intercellular communication
26

, disease propagation

27

, and their potential use as gene therapy vectors

28

. The C-CP

fibers, extruded from commodity polymers (nylon 6, polypropylene, and poly (ethylene
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terephthalate) (PET)), have a unique cross-sectional profile that can render thousands of 14 μm-wide parallel channels when packed in column formats, providing high permeability
to fluid flow 29. The unique fiber shape and high permeability of the C-CP column result
in the ability to perform biomolecule separations at exceedingly high linear velocities (>50
mm sec-1) without mass transfer limitations 29-32. The latter characterstic is due to the virtual
non-porosity of the fiber phases versus the size of the vesicles. With the success of using
this PET C-CP fiber column HIC method for the separation of proteins 33,34 and EVs 22-25,
this study expands the use of the platform to the efficient and inexpensive isolation and
purification of lentivirus from cell culture media. As EVs and lentivirus share features,
including size and general surface chemistries, extension of the isolation method was
pursued, and may be adapted for lentivirus recovery from a diverse range of media on the
clinical, laboratory, and production scales.
5.3 Material and methods
Chemicals and instrumentation
Ultra-pure grade ammonium sulfate (NH4)2SO4 and biotechnology-grade glycerol
were purchased from VWR (Sokon, OH, USA), phosphate-buffered saline (PBS) (10X)
was purchased from Hyclone Laboratories. Inc. (Logan, UT, USA) and diluted with ultrapure water (18.2 M Ω cm) obtained from a Millipore water system (Billerica, MA, USA).
All chromatographic measurements were performed on a Dionex Ultimate 3000
HPLC system (LPG-3400SD quaternary pump and MWD-3000 UV–Vis absorbance
detector; Thermo Fisher Scientific, Sunnyvale, CA, USA) and controlled by the
Chromeleon 7.0 software system. Detection at 216 nm was used post-column, as in the
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case of a standard HPLC experiment. As in the case of EVs [21,22], the absorbance detector
in this case is responding to scattering via the vesicles, and not due to actual absorptivity.
Isolated fractions from the HPLC were collected using an R1 fraction collector (Teledyne
Isco, Lincoln, NE, USA).
Microbore C-CP fiber column construction
The PET C-CP fiber column manufacture has been described in a previous
communication 35. Eight rotations of PET fibers (equaling 450 single fibers) were rinsed
with hot water, acetonitrile, and water, then pulled through 30-cm polyether-ether-ketone
(PEEK) tubing with an inner diameter of 0.76 mm (IDEX Health & Science LLC, Oak
Harbor, WA, USA). After packing, the column was washed with Milli-Q water, ACN, and
Milli-Q water, successively, at a flow rate of 0.5 mL min-1 on the HPLC system until a
stable baseline was observed with the UV–VIS absorbance detector (216 nm). Once
assembled and cleaned, the microbore columns were stored in ambient conditions. The
columns were cut into 5 cm length for later use.
Lentivirus culture
The 293T cells (ATCC, CRL-3216) were grown in a 37℃ and 5% CO2 incubator
with the culture medium containing Dulbecco’s Modified Eagle’s Medium (DMEM,
Corning, 10-013-CM), 10% fetal bovine serum (Corning, 35-011-CV), 1,000 units mL-1
penicillin and 1,000 μg mL-1 streptomycin (Gibco, 15140-122). Lentiviruses were
produced by transfecting the 293T cells with pEGIP plasmid (Addgene, 26777) and
lentiviral package mix (Invitrogen, K497500) following the instructions provided by
Invitrogen. One night before transfection, 5×106 293T cells were seeded in a 10 cm cell-
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culture petri dish. The DNA- Lipofectamine 2000 complexes containing 3 μg of pEGIP
plasmid, 9 μg of packaging mix, and 36 μL of Lipofectamine 2000 (Invitrogen, 11668019) were added dropwise to the cells. The following day, the medium was replaced with
fresh medium containing DMEM, 10% fetal bovine serum, and 10 mM sodium pyruvate
(Gibco, 11360-070). After 72 hours of incubation, the virus-containing supernatant was
harvested, centrifuged at 1000 g for 15 minutes, filtered with 0.45 μm filter (Millipore),
and stored at -80°C.
Liquid chromatography isolation method
Columns were equilibrated with 2 M (NH4)2SO4 solution dissolved in PBS, pH =
7.4, which also served as the loading medium. After loading 20 µL lentivirus samples for
1 min, two gradient steps were employed, the first consisting of 25 % glycerol with 1 M
(NH4)2SO4 for 4 min and the second of 50% glycerol in PBS for 5 min. Separations were
performed with a mobile phase flow rate of 0.5 mL min-1.
Different (NH4)2SO4 concentrations (2 M, 1.5 M, and 1M) and glycerol
concentrations (10%, 15%, 20%, and 25%) at the loading step were optimized. The first
and second gradient steps were performed as described in the previous paragraph.
Different glycerol concentrations (20%, 25%, 30%, and 35%) at the first gradient
step were optimized, with a fixed (NH4)2SO4 concentration (1.5 M). The loading step was
performed under optimized (NH4)2SO4 and glycerol concentrations for 1 min, and the
second gradient step was performed with 50% glycerol for 5 min. The flow rate was kept
at 0.5 mL min-1. Again, 20 µL of the sample was loaded.
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Lentivirus quantification
A room temperature, qPCR method was employed for quantitatively titrating
lentivirus. A kit (LV900) from Applied Biological Materials (ABM) Inc. was revised based
on the manufacturer’s instructions. Briefly, 5 µL viruses in the stock or elution samples
were lysed with 5 µL virus lysis buffer for 5 min at room temperature to release the viral
RNA and form the viral lysate. Then, 1 µL viral lysate, 5 µL 2X qPCR Supermix (BIORAD, 1725121), and 4 µL reagent-mix were added to the 96-Well PCR Plates
(Multiplate™) and capped with ultraclear PCR caps (BIO-RAD, TCS0803). The plate was
then centrifuged at 200 x g for 1 min to mix the solutions. The qRT-PCR program was
performed according to the instruction. Two standards containing known concentrations of
viruses provided by the kit, STD1, and STD2, were examined simultaneously. The
concentrations of the lentivirus in the stock or samples were calculated by comparing it to
the two standards. Because the sample was diluted 1:2 during the lysis step, the
concentration of the virus in the sample = 2 X 5 X 107/23(Ctx-Ct1)/(Ct2-Ct1), where Ctx is the
average of 3 threshold cycle (Ct) values of the sample, Ct1 is that of the STD1 and Ct2 is
that of the STD 2, with the unit of the concentration being particles per mL. The
concentration of the viruses in the samples or elution were calculated based on the equation.
On-fiber characterization of lentivirus processing
In order to verify their capture and characterize the microscopic morphology of
lentiviruses on the C-CP fiber surfaces, a scanning electron microscope (Hitachi S-4800,
Tokyo, Japan, Clemson University Electron Microscopy Facility) was used. The fiber
columns were cut into 5-cm segments and installed on the HPLC instrument, with 20-μL
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exosome samples loaded and eluted according to the optimized HIC method (loading with
1.5 M (NH4)2SO4 and 15% glycerol for 1 min, followed by a first step gradient of 20%
glycerol and 1 M (NH4)2SO4 for 4 min, and a second step gradient of 50% glycerol for 5
min). Three column samples were collected : after the injection step (2 min), after the first
gradient step (5 min) and after the second gradient step (10 min). The fixing and staining
steps were performed following the previous procedure 36. Briefly, each column was cut
to 0.5-cm length and rinsed in a mixture of 2% osmium tetroxide and 2 M (NH4)2SO4
solution (1:1 v/v) for 30 min to fix and stain the captured lentiviruses. Distilled water, with
50%, 70%, 80%, 90%, 95%, and 100% ethanol and a 50–50 hexamethyldisilazane
(HMDS)–ethanol was performed for 3 min, respectively, to remove the osmium tetroxide
and dry the fiber surface. The fibers were then left in HMDS overnight until the solution
was fully evaporated.
The fibers were extracted from the tubing and fixed to the SEM holder using
double-sided tape and then sputter-coated with platinum at 70 mTorr argon for 2 min using
a Hummer 6.2 Sputtering system (Anatech USA, Union City, CA, Clemson University
Electron Microscopy Facility).
5.4 Results and discussion
Viability of Lentivirus in Potential Elution Solvents
We recently reported a method via HIC with PET C-CP fibers, which provides an
efficient way to isolate exosomes.37 It is important to note that when using the commonly
applied differential centrifugation, ultracentrifugation, and several commercially available
kit isolation methods, there is still substantial carryover of undesirable sample impurities,
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such as host cell proteins (HCPs). Given the time consumption and low specificity of these
methods, which are limiting in terms of development of downstream isolation and
quantification of schemes, we have pursued a new method alleviating these pretreatment
steps and directly loading filtered human urine on to the C-CP fiber columns.
Table 5.1 qPCR-determined concentrations of lentivirus in 50% glycerol, PBS, and 40%
acetonitrile at 2 x dilution with different incubation times at 4 °C. Original concentration = 5.74 x
106 per mL (n = 3 replicates for each sample)

Incubation
Time
(min)

Concentration of Virus
(*106 viruses per mL
following 2x dilution)

% RSD

Overall
Recovery

50% glycerol

10

1.97

0.46

68.6%

50% glycerol

30

2.24

0.27

78.0%

50% glycerol

60

2.68

0.35

93.3%

40% ACN

10

0.134

1.50

4.67%

PBS

60

2.10

0.80

73.2%

Solvent

Selectivity and resolution in HIC separations are often improved by the addition of
modifiers to the elution solvents, such as alcohols (e.g., methanol, ethanol, glycerol),
acetonitrile (ACN), detergents, or chaotropic salts

38

. In our previous studies of EVs

separation using HIC, acetonitrile (ACN) and glycerol were used as solvent modifiers
based on their intermediate polarity 22-24. In the case of vesicular analytes, there is concern
about the potential effects of ACN on membrane structure. Alternatively, glycerol is a
nontoxic,solute-compatible solvent having few negative effects
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39

. Marshall et al.

demonstrated that viruses could survive for at least 4 weeks when stored in 50 - 98%
glycerol at 4 °C 40, suggesting that glycerol might be a more suitable solvent modifier than
ACN for lentivirus purifications. Relative to the proposed HIC separation process,
lentiviruses were mixed in 50% glycerol and incubated for up to 1 h (a relevant analysis
time scale) at 4°C and their RNA concentration assessed using q-PCR. A 10 min incubation
in 40% ACN was also tested.
As shown in Table 5.1, triplicate assays for 10, 30, and 60-minute incubations in
50% glycerol were not statistically different from the recoveries of a sample stored for 1
hr in PBS. Conversely, RNA recoveries were profoundly reduced upon exposure to ACN.
However, it is not sufficient to conclude that the reduction in RNA recoveries is due to
vesicle destruction. To assess potential solvent effects on the actual q-PCR test, an RNA
standard was mixed in 50% glycerol, 2 M ammonium sulfate, 40% acetonitrile, and PBS
without incubation and measured.
Table 5.2 qPCR-determined concentrations of RNA standard in 50% glycerol, PBS, 40%
acetonitrile, and 2 M ammonium sulfate without incubation at 4 °C (n = 3 replicates for each
sample)

Concentration of RNA
(*106 RNA per mL)

% RSD

Recovery

50% glycerol

7.18

1.94

143.6%

40% ACN

5.61

0.96

112.2%

2 M (NH4)2SO4

N/A

N/A

0%

PBS

6.12

1.17

122.2%

Solvent
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As shown in Table 5.2 and Table A2, the sample in the ammonium sulfate solvent
yielded undetectable amounts of RNA (like due to the high salt content/ionic strength),
while the others showed no significant effects, based on the 90% confidence inteval. This
suggests that ACN does perturb the lentivirus structure, resulting in the dramatically
reduced recoveries, while glycerol is a viable solvent for both virus elution and q-PCR
testing.

Fig. 5.1 Chromatogram of lentivirus isolation employing a step-gradient HIC method. 20-μL
injection of cell media (~1.2 x 105 particles) into 2 M (NH4)2SO4 in 1 x PBS. Gradient steps of 25%
glycerol with 1 M (NH4)2SO4 at 1 min and 50% glycerol 5 min were performed. Separations were
performed with a mobile phase flow rate of 0.5 mL min−1. Tabulated values reflect n = 3 replicates,
with all values showing <7 %RSD variability

Fig. 5.1 depicts a representative chromatogram of lentivirus isolation for a 20 μL
injection of cell media monitored by UV-Vis absorbance at 216 nm. This test program is
a simple extension of that used previously for EVs isolation 24. The intense absorbance in
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the first minute reflects the elution of non-retained species (salts and assorted small
molecules), as well as free RNA during the loading step. Analogous to previous EVs
isolation programs, the more hydrophobic proteinaceous material

22,23

, is retained on the

PET fiber surfaces, and subsequently eluted in the first gradient step with the band eluting
between 2-5 min. Finally, again analogous to EVs, the lentivirus elutes in the second step
in a band spanning from ~6.5-8.5 min. Based on qPCR analysis of the three eluting
fractions, this preliminary isolation program yields lentivirus densities of 7, 0, and 3205
particles mL-1 for the respective bands, reflecting high levels (>99%) of virus particle
recovery versus the pass through and first elution fractions.
Evaluation of Step-Gradient Parameters
To better understand the influences of the gradient solvent composition in the first
two steps, the mobile phase content was varied. The choice of loading mobile phase
composition for solid-phase isolation is based on finding thermodynamic (enthalpic,
chemical) and kinetic (hydrodynamic) conditions under which the target solutes are
retained on the phase, while non-target solutes pass through in the injection band. In the
lentivirus isolation from the cell culture matrix, this is done not only to obtain high
lentivirus purity but also to provide the maximum amount of solid phase surface area to
affect the lentivirus loading.
To evaluate the ability to solely retain lentivirus, different loading (injection)
mobile phase concentrations (from 1-to-2 M (NH4)2SO4 and 10-to-25% glycerol) were
evaluated, respectively, for isolation of lentivirus particles. It was anticipated that the
propensity for retention of proteinaceous species would vary with salt concentration.
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Fig. 5.2 Chromatogram of lentivirus isolation employing a step-gradient HIC method. 20-μL
injection of cell media (~1.2 x 105 particles) into different (NH4)2SO4 concentrations in 1 x PBS as
the initial solvent. Gradient steps of 25% glycerol with 1 M (NH4)2SO4 at 1 min and 50% glycerol
5 min were performed. Separations were performed with a mobile phase flow rate of 0.5 mL min−1.
Tabulated values reflect n = 3 replicates, with all values showing <7 %RSD variability

As shown in Fig. 5.2, the retention of proteins was dependent on injection solvent
content, with the recovery of that band dropping by 70% with 1.5 M (NH4)2SO4 and to
non-determinant levels at the lowest salt content. Additionally, the apparent recoveries of
the lentivirus fraction based on the integrated absorbance decreased by ~5% and 40% with
decreased salt content. In fact, based on qPCR results (detailed qPCR results presented in
Appendix Table A3), the actual virus recoveries were 8X higher at the 1.5 M level than the
2 M (NH4)2SO4, suggesting that viral RNA content may have been jeopardized at the
highest salt composition (as perhaps suggested by the results in Table 5.2). That said, the
lower salt content in the loading mobile phase did yield qPCR values proportional to the
decrease in absorbance, with the 1 M loading yielding approximately one-half that of the
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1.5 M load composition. Based on the trade-offs between protein carry-over and total virus
recovery, a loading solvent of 1.5 M (NH4)2SO4 was chosen for subsequent studies.

Fig. 5.3 Chromatogram of lentivirus isolation employing a step-gradient HIC method. 20-μL
injection of cell media (~1.2 x 105 particles) into 1.5 M (NH4)2SO4 in 1x PBS at different glycerol
concentrations as the initial solvent. Gradient steps of 25% glycerol with 1M(NH4)2SO4 at 1 min
and 50% glycerol 5 min were performed. Separations were performed with a mobile phase flow
rate of 0.5 mL min−1. Tabulated values reflect n = 3 replicates, with all values showing <7 %RSD
variability

As demonstrated in EV isolation, glycerol can be an effective mobile phase additive
in a microvesicle elution program 23. The chromatograms of Fig. 5.3 depict representative
responses under different glycerol concentrations in the loading step, with a fixed 1.5 M
(NH4)2SO4 concentration. As the glycerol concentration is increased from 10 to 25%, the
absorbance attributed to proteins in the first elution peak decreased to non-determinant
levels with a minimal reduction in the peak area of the lentivirus elution band. The table
insert provides a comparison of the integrated absorbance and qPCR data corresponding to
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the second (virus) elution peak results (detailed qPCR results presented in Appendix Table
A4). The integrated absorbance dropped slightly when the loading glycerol concentration
increased to 15%, while the lentivirus recovery increased by ~10%. This response supports
the concept that reduced protein adsorption enhances virus retention and recovery as there
is more effective surface area for virus adsorption as less proteinaceous material is retained
in the loading step. As the glycerol concentration is increased further, the virus recoveries
based on both the absorbance and qPCR results drop. (The more appreciable drop in the
qPCR recoveries may be inhibited viral lysis as a result of loading under high glycerol
conditions.) Based on these results, a 15% glycerol concentration was chosen as the optimal
loading concentration.

Fig. 5.4 Representative chromatogram of lentivirus isolation employing a step gradient HIC
method as a function of the elution solvent glycerol content. 20-μL injection of cell media (~1.2 x
105 particles) into 1.5 M (NH4)2SO4 in 1 x PBS and 15% glycerol concentrations as the initial
solvent. Gradient steps of different glycerol concentrations with 1 M (NH4)2SO4 at 1 min and 50%
glycerol 5 min were performed. Separations were performed with a mobile phase flow rate of 0.5
mL min−1. Tabulated values reflect n = 3 replicates, with all values showing <7 %RSD variability
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The mobile phase composition of the first elution step should primarily affect the
efficient elution of the proteinaceous materials, while seeking to retain the lentivirus
recovery. If the glycerol concentration is too low, proteins and other impurities may be
retained on the fiber surface during this step, only to elute along with the lentivirus during
the second elution step, compromising the recovered virus purity. Alternatively, if the stepone elution strength is too high, lentivirus particles may be eluted with the proteins. To
determine the effects on lentivirus isolation in the second fraction, glycerol concentrations
in the first elution step were varied from 20-to-35% at a fixed 1 M (NH4)2SO4
concentration. The optimized loading mobile phase (15% glycerol with 1.5 M (NH4)2SO4)
was employed. As depicted in Fig. 5.4, as glycerol concentration increased, the peak area
and concentration of lentivirus decreased slightly, until the 30% glycerol value where the
qPCR-based recovery dropped results (detailed qPCR results presented in Appendix Table
A5). The corresponding changes in the absorbance response of the first elution band
showed little change up to 30% glycerol, where a marked increase is observed. These
responses suggest that as glycerol content increases, weakly-bound virus particles (perhaps
suggestive of different populations) are eluted in the same step-band as the proteins. Based
on the cumulative responses (Figs. 5.2-5.4), and the supporting qPCR results, the optimized
process for lentivirus isolation from culture media includes: injection in 15% glycerol in
1.5 M (NH4)2SO4: PBS, a first-step elution mobile phase composition to 20% glycerol in
1 M (NH4)2SO4: PBS and virus elution in a 50% aqueous glycerol solution. Under these
conditions, lentivirus particles can be harvested from cell culture media at high purity and
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appreciable yield. Based on the initial injection of ~1.2 x 105 particles (20 μL of ~6 x 106
particles mL-1) and determined qPCR densities of >5 x104 mL-1 across an elution volume
of 1.5-2 mL, recoveries of >75% are realized. (Improved quantification of the recovery
would require the use of higher-fidelity fraction collection as only ~3s of the elution band
is sampled.) The ability to achieve this level of efficiency and freedom from carry-over of
media components and proteinaceous materials within a 10 min gradient program
represents a step change in virus processing capabilities. For example, Yamada et al.
purified lentivirus with anion exchange chromatography where the recovery was less than
50% with an elution time over 40 min

14

. Methods involving ultracentrifugation and

filtration require far greater processing times and have appreciably greater amounts of
protein carryover.
Visualization of the Lentivirus Processing
To complement the chromatographic and qPCR results presented above, scanning
electron microscopy (SEM) was used to visualize lentivirus capture/elution along the step
gradient processes.

Fig. 5.5 presents micrographs of C-CP fibers (removed from the

column casing) taken at 3 magnifications following completion of each chromatographic
process: post-injection, post-protein elution, and post-virus elution. These examples come
from 3 different columns operated to those points in the process.
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Fig. 5.5 SEM images of extracted PET C-CP fibers from columns following exposure to 20-μL
injection of cell culture milieu. a–c Following sample injection. d–f Following protein elution step.
g–i Following virus elution step. In each case, scale bars represent 100 μm, 5 μm, and 1 μm from
left to right

Micrographs in Figs. 5.5a-c are of fibers extracted from a column following the
initial loading step.

The lowest magnification shows the channel structure of multiple

fibers, with the higher magnifications showing objects of both crystalline and globular
structure. The crystalline entities are the result of the ammonium sulfate mobile phase
drying in the channels. Further magnification reveals smaller individual bodies of the size
expected of the virus particles (~100 nm) as well as likely agglomerates. The micrographs
taken following the protein elution step (Figs. 5.5d-f) look similar to the as-injected case,
excepting the lack of salt crystals. This is expected as the larger bodies are likely to be
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very hydrophobic, and any loss of adsorbed proteins would not be visible at the SEM
resolution. Finally, the post-virus elution micrographs (Figs. 5.5g-i) reveal surfaces
virtually devoid of bodies of the size of virus particles, with the much larger (hydrophobic)
entities remaining on the surfaces; perhaps agglomerates of the particles. The presence of
these species on the fiber surfaces is considered a positive attribute as the presence of
aggregates in the collected virus fractions might be problematic.
5.5 Conclusions
The first chromatographic isolation of virus particles based in the vesicles’
hydrophobic character has been demonstrated. A step-gradient HIC method employing a
PET C-CP fiber column for the purification of lentiviruses from a cell culture matrix is
described. The approach is an extension of previous efforts in the isolation of EVs from
diverse media 23,24. Injection of the cell culture supernatant under HIC conditions results in
the initial pass-through of salts, amino acids, and free genetic material. The procedure was
optimized by varying the concentration of the salt (ammonium sulfate) and modifier
(glycerol) to affect the relative retention of proteins and the target virus material. Standard
post-column absorbance detection and qPCR assays provide complementary information
about the efficiency of the processes. As in the case of EVs, it may be eventually realized
that method could provide quantitative information of particle densities, though methods
such as multiangle light scattering spectrometry (MALS) could be readily implemented
post-column to assess virus particle size. Ultimately, the two-step gradient program can
be effective for high purity and yield (>75%) of virus particles. SEM imaging of fiber
surfaces provides further insights into the on-column processes. The use of the novel PET
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C-CP fibers in a microbore column with HIC provides an affordable and efficient means
of lentivirus purification from the cell culture matrix within 10 minutes on a standard
HPLC system equipped with absorbance detection. While not studied here, by analogy to
exosome studies, per column virus particle loading capacities of the order of >109 in a
single separation may be projected 24. Based on these efforts, a single microbore column
performs effectively for over 30 injections of cell culture supernatant without any notice
of ill effects such as clogging (via increased back pressure) or by degraded
chromatographic performance. More rigorous evaluation of the column longevity remain
to be performed.
Table 5.3 Comparison of lentivirus isolation methods
Method

Volume

Method Process

Instrument and
materials

Prices

Ultracentrifugation
(UC)

45 mL

Filter + UC

$120/100
filters

Ultrafiltration (UF)

30-45 mL

Ion-exchange
chromatography
(IEC)

0.5 mL

UF +
Centrifugation
Centrifugation+
IEC + filtration

UC
Instruments,
filters
Amicon Ultra
100 K filter
HiTrapTMQ
Anion
exchange
column,
centrifugal filter
device

Affinity
chromatography

35 mL

Size exclusion
chromatography
(SEC)

0.5–1 mL

Sucrose gradient
centrifugation

30 mL

Filtration+
Centrifugation

Fractoge®
EMD Heparin
column
SEC qEV
column and
TRPS
instrument
(qNANO)
Sucrosecontaining
buffer, filters

PET C-CP HIC
separation

20-100
𝜇L

HIC separation

Filtration +
Affinity
separation
Centrifugation+
Filter + SEC

PET C-CP
column
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Operation
Time
(Including
sample
preparation)
3h

Reference

>1 h

12 13

>40 min

14

$120/100
filters,

>1 h

17

$249/5
columns

Insufficient
detail
provided

13

$120/100
filters,
$150/500g
curcrose
$5 per
column

1.5-4 h

13 19

< 20 min

This work

$119/8
filters
~$50 per
column,
~$50 per
filter

12

,

,

It is difficult to place the practical aspects of the various virus isolation protocols
into context as they have been developed towards different end results, analytical,
preparative, etc. Table 5.3 presents a compilation of the methods cited previously along
with the HIC method developed. The present analytical scale separation strategy may be
further refined via detailed evaluation of operational parameters including the column fiber
packing density and the role of mobile phase linear velocity. While a one-variable-at-atime (OVAT) was applied in this preliminary evaluation, though design-of-experiment
(DoE) approaches inclusive of greater parameter diversity could be applied in future
efforts. There remains a need for better understanding of inconsistencies between the
absorbance and qPCR recoveries under high glycerol conditions. The scale-up of the
benchtop methodology to industrial preparative-scale purification of virus particles is
foreseeable based on previous hydrodynamic studies of protein separations, increased
column capacity could be affected through either the use of longer columns of the same
diameter or use of larger-diameter columns packed to equivalent interstitial fractions 29,41.
Here again, advantages of extremely low fiber costs and high overall permeability are
practical advantages. Ultimately, an extension of the HIC method on C-CP fiber columns
to other forms of bio-nanoparticles employed as gene therapy vectors is also envisioned.
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CHAPTER VI
SEPARATION OF PROTEINS WITH WIDE-RANGING MOLECULAR WEIGHTS
VIA REVERSED-PHASE LIQUID CHROMATOGRAPHY METHODS WITH
TRILOBAL POLYPROPYLENE CAPILLARY-CHANNELED POLYMER (C-CP)
FIBER COLUMN
6.1 Abstract
Reversed-phase

liquid

chromatography

(RPLC)

and

size-exclusion

chromatography (SEC) methods are commonly used for protein separations based on
distinct principles. RP methods have been previously used for size-based separation of
protein mixtures but are expensive and limited to proteins with small molecular weights
(up to 75 kDa) based on mass transfer limitations. Alternatively, SEC provides
complementary benefits in the separation of higher-mass proteins. In this study, a novel
polypropylene Y-shaped (trilobal) (PPY) capillary-channeled polymer (C-CP) fiber
column was used with a reversed-phase method for the separation of a commercial protein
standard (molecular weight ranges from 1.4 to 660 kDa) and an addition protein mixture.
Chromatographic parameters including gradient times (6 - 20 min), flow rates (0.2 - 1.0
mL min-1) and TFA concentrations (0.5 - 2% TFA) in the mobile phase were optimized to
affect high resolution and throughput. Following the optimization, the performance of the
trilobal fiber column was compared to commercial-sourced C4 and SEC columns, both of
which are sold specifically for protein separations and operated according to the
manufacturer-specified conditions. In comparison to the C4 and SEC columns, the PPY
C-CP column yielded better separation performance (higher resolution), at much lower cost
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(< $15 for PPY C-CP column materials versus $750 for the C4 and $2550 for SEC the
columns), and shorter separation times (10 min versus 25 min). This effort has yielded a
rapid, low-cost, and efficient method for protein separation of proteins of wide-ranging
molecular weights.
6.2 Introduction
There is considerable interest in the liquid chromatography (LC) separation of
proteins, inclusive of an incredible diversity of size ranges. The most popular methods
used for protein separation are reversed-phase liquid chromatography (RPLC)1-3 and sizeexclusion chromatography (SEC).4-5 In the case of RPLC, the binding of solute to the
stationary phase is predominantly mediated by hydrophobic interactions between the
nonpolar amino acid residues of proteins and immobilized n-alkyl ligands acting as the
stationary phase.6 The solutes are initially applied to the sorbent in the presence of aqueous
buffers and then eluted in order of increasing molecular hydrophobicity using a gradient of
increasing organic solvent (lower polarity) to the mobile phase.6 While highly versatile in
applications of complex mixture separations and interfacing with mass spectrometry, high
molecular weight (>~75 kDa) proteins are challenging in terms of poor mass transfer
characteristics and potential irreversible binding.
Size exclusion chromatography provides a complementary approach to protein
separations. On a first principle basis, SEC is an entropically-controlled separation
technique, depending upon the relative size or hydrodynamic volumes of a macromolecule
with respect to the average pore size of the packing.7 Briefly, the sample is transported by
a suitable mobile phase (which minimizes enthalpic interactions) through a column packed

126

with porous particles with defined pore diameters. Retention occurs when the molecule is
able to diffuse into the particles of the support phase. Larger molecules are less retained
(excluded) due to the decreased ability to access the interior of the packing materials.8
When compared with RPLC, the SEC method produces relatively low-resolution (low peak
capacity) separations with a limited applicability range.9 Thus, for analytical purposes,
SEC is only suitable for analyzing low-complexity samples, and is thus generally regulated
to quality control applications.4,

10

Recently, Chien et al. employed a reversed-phase

column (C4) to act as an SEC column to separate proteins based on the molecular weights.11
Results show that high concentrations (up to 70%) of acetonitrile with trifluoroacetic acid
as an acid modifier successfully suppressed interactions between proteins and the
stationary phase. However, the commercialized C4 RP column has a high cost (~$ 700 per
column) and limited protein separation size (no large than 150 kDa). Ultimately, there is
high demand to find column formats which allow for RP-type separations of high
molecular weight (upwards of 600 kDa) proteins, though at lower costs and operational
complexity.
In the last two decades, Marcus and coworkers have successfully employed
capillary-channeled polymer (C-CP) fibers as the stationary phase for protein,12-14
exosome,15-17 and lentivirus18 separations. C-CP fibers are extruded from polypropylene
(PP), polyester (PET), and nylon 6-based polymers in the form of 30–50 𝜇m diameter
fibers having eight channels running along their periphery.19-20 This diversity of base
materials, along with facile surface modifications, provides platforms for RP,19,

21

ion

exchange (IEX),22-23 hydrophobic interaction (HIC),17, 24 and a variety of immunoaffinity

127

mode protein separations.25-26 Importantly, the 1–4 μm spacing between the fiber channels
provides free flow of proteins in viscous media without significant fouling.20, 27 In fact, the
construct provides for protein separations at significantly lower back pressures (< 1000 psi)
and higher linear velocities (> 50 mm s−1) than traditional porous bead support phases.
Recently, a Y-shaped trilobal, polypropylene fiber structure (referred to as PPY) was
described and its performance compared to the typical eight-channeled shape for reversedphase protein separations.12, 28 Ultimately, with more uniform packing (lower van Deemter
A-term), the PPY columns yield elution peaks with greater symmetry and higher separation
efficiency (resolution) than the previous eight-channel fiber geometry.12,

28

As found

previously,27 the fibers of very limited porosity, thus the PPY column could potentially be
used for the separation of proteins with wide-ranging molecular weights without sacrifice
to chromatographic quality.
This study seeks to develop and evaluate an RP-LC method with a PPY C-CP
column to separate proteins across wide-ranging molecular weights (1.4 to 660 KDa) and
hydrophobicity. In this report, different gradient rates (6, 8, 10, 12, 16, 20 min), flow rates
(0.2, 0.4, 0.6, 0.8, 1.0 mL min-1), and TFA concentrations (0.05%, 0.1%, 0.2% TFA) were
evaluated to understand and optimize the separation qualities. Once optimized, the
performance of the PPY fiber column was compared to a commercially-available
superficially porous, reversed-phase column (BIOshellTM C4 column) and a commerciallyavailable SEC column (Xbridge® SEC column), both of which are sold towards
applications in protein analysis.

Initially, a commercial SEC protein standard (vitamin

B12, chicken albumin, equine myoglobin, bovine gamma-globulin, and thyroglobulin) was
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employed as the test mixture, with a subsequent synthetic protein mixture (vitamin B12,
cytochrome c, equine myoglobin, bovine gamma-globulin, and thyroglobulin) employed
for the critical evaluation. On-line UV-Vis absorbance detection at 216 nm was used to
monitor the separation of the proteins. Based on chromatographic figures of merit,
separations with PPY C-CP columns showed better efficiency and resolution for the protein
mixture separations. This method provides an affordable and efficient means of separating
proteins with wide-ranging molecular weights.
6.3 Material and methods
Chemicals and instrumentation
Acetonitrile (ACN) and trifluoroacetic acid (TFA) were purchased from VWR
(Sokon, OH, USA), phosphate-buffered saline (PBS) (10X) was purchased from Hyclone
Laboratories. Inc. (Logan, UT, USA) and ultra-pure water (18.2 M Ω cm) was obtained
from a Millipore water system (Billerica, MA, USA). The SEC protein standard (gel
filtration 1350-670,000 Da MW) was purchased from Bio-Rad (Hercules, CA, USA),
which is a mixture of vitamin B12 (VB12), chicken ovalbumin (OVA), equine myoglobin
(myo), bovine gamma-globulin (BGG), and thyroglobulin (Tg). Of the individual proteins
VB12 was purchased from VWR (Sokon, OH, USA), and OVA, cytc, myo, bovinBGG,
and Tg were purchased from Sigma Aldrich (St. Louis, MO, USA). Potassium phosphate
monobasic and sodium phosphate dibasic were purchased from Sigma Aldrich (St. Louis,
MO, USA). The commercial superficiously-porous C4 column (BIOshellTM IgG 1000Å
C4 column (3 cm x 2.1 mm, 2.7 μm)) was purchased from Sigma Aldrich (St. Louis, MO,
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USA). The SEC column (Xbridge® BEH 200 Å SEC 3.5 𝜇m, 7.8 x 150 mm) was purchased
from Waters (Milford, MA, USA).
All chromatographic measurements were performed on a Dionex Ultimate 3000
HPLC system (LPG-3400SD quaternary pump and MWD-3000 UV–Vis absorbance
detector; Thermo Fisher Scientific, Sunnyvale, CA, USA) and controlled by the
Chromeleon 7.0 software system.
Microbore C-CP fiber column construction
The PPY C-CP fiber column manufacture has been described in a previous
communication.12 Briefly, eight rotations of PPY fibers (~ 560 fibers) were heat shrunk
using boiling water and then cleaned sequentially using room temperature Milli-Q water,
acetonitrile, and Milli-Q water to remove any latent anti-static spin-coating.12 The fiber
loop was pulled through 30-cm long polyether-ether-ketone (PEEK) tubing with an inner
diameter of 0.76 mm (IDEX Health & Science LLC, Oak Harbor, WA, USA). After
packing, the column was flushed with Milli-Q water, ACN, and Milli-Q water,
successively, at a flow rate of 0.5 mL min-1 on the HPLC system until a stable baseline was
observed using UV–VIS absorbance detection (216 nm). Once assembled and cleaned, the
microbore columns were stored under ambient conditions. The columns were cut to the
desired 30 cm length for subsequent use.
Protein solution preparation
Two synthetic protein mixtures were employed in this effort, with the
chromatographically relevant aspects for each provided in Table 6.1. Key here is the very
wide diversity of molecular weights, ranging from 1.4 to 660 kDa. The size dimension of
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the proteins shown in Table 6.1 were simulated with the protocol based on the an Inertia
Axis Aligned Bounding Box (IABB)29 with the 3D structure of each protein from protein
data bank(PDB). The commercial Bio-Rad SEC protein standard was dissolved in 1X PBS
and diluted to 1 mg mL-1, which has VB 12 (1.4 kDa), myo (17.2 kDa), OVA (42.7 kDa),
BGG (150 kDa), and Tg(660 kDa). The protein mixture contains VB 12, cytochrome c
(cytc), myo, BGG, and Tg with the concentration of 0.05, 0.2, 0.2, 0.2, 0.2, and 0.4 mg mL1

respectively. VB 12, OVA, cytc, myo, BGG, and Tg were prepared individually with

concentrations of 0.05, 0.2, 0.2, 0.2, 0.2, and 0.4 mg mL-1, respectively in 1X PBS.

Table 6.1. Size of different proteins.

Liquid chromatography separation methods
In this study, the separation of proteins with wide-ranging molecular weights using
the C-CP fiber column was compared to with another RP-LC method using a superficiously
porous C4 column and a size-exclusion chromatography method using an SEC column. All
methods shared the same parameters, such as equilibration time (1 min) and injection
volume (5 μL). The eluted proteins were monitored with a UV absorbance at 216 nm at
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room temperature. The baseline absorbance was obtained by running the methods without
sample injection and subtracted from the separation chromatogram. Each separation was
performed three times for each sample/column type. Tabulated data are presented as the
average values of triplicate experiments, with demonstrative chromatograms presented in
the figures.
PPY C-CP column: As a baseline set of conditions, the column was equilibrated
with 100% mobile phase A (100% DI water with 0.1% TFA) for 1 min, which also serves
as the loading medium. A 10-min linear gradient was performed from 100% mobile phase
A to 100% mobile phase B (100 % ACN with 0.1% TFA) with a flow rate of 0.5 mL min1

. Then, the operation parameters, such as different gradient time (6, 8, 10, 12, 16, 20 min),

flow rates (0.2, 0.4, 0.6, 0.8, 1.0 mL min-1), and TFA concentrations (0.05%, 0.1%,
0.2%TFA) were optimized in a one variable at a time (OVAT) approach.
C4 column: The manufacturer-suggested method was followed with only a slight
modification. Briefly, the column was equilibrated with 80% mobile phase A (100% DI
water with 0.1% TFA) and 20% mobile phase B (100 % ACN with 0.1% TFA) for 1 min,
which also serves as the loading medium. A 30-min linear gradient was performed from
80% A:20% B to 60% B at a flow rate of 0.4 mL min-1. This initial gradient was extended
from 20%-60% B to 20%-100% B to affect the elution of Tg, as it cannot be eluted from
the column using the initial method. This extension does not effect the chromatographic
characteristics of the other proteins.
SEC column: The method was performed according to the column manufacture’s
instructions. Briefly, the column was equilibrated with the mobile phase (100 mM
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phosphate buffer, pH 6.8) and a 20 min isocratic elution was performed at a flow rate of
0.86 mL min-1.
6.4 Results and discussion
Protein separation with the PPY C-CP fiber column
In comparison to traditional porous bead RP columns formats employing C4 and
C18 stationary phases, the C-CP column has advantages in terms of column high
permeability but an effectively non-porous fiber phase structure, allowing for protein
separations with high linear velocities without significant van Deemter C-term
broadening.19-20 To initially evaluate the separation of proteins with wide-ranging
molecular weights with C-CP columns, a PPY C-CP column was utilized for separating
the commercial 1 mg mL-1 SEC protein test mixture, using what are ‘typical’ fiber column
separation conditions.

Fig. 6.1. Chromatography of proteins separation with PPY C-CP column. a) 5 μL of the SEC
standard and the individual proteins (0.05, 0.2, 0.2, 0.2, 0.4 mg mL-1 of VB12, chicken ovalbumin,
equine myoglobin, bovine gamma-globulin, thyroglobulin, respectively). b) chicken ovalbumin
was replaced by 0.2 mg mL-1 of cytochrome c. A 10-min gradient (0.1% aqueous TFA to ACN +
0.1% TFA) was performed at a flow rate 0.5 mL min-1.
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As seen in Fig. 6.1a, the chromatogram of the mixture reflects more than the
expected number of peaks. To determine the retention times of each protein, single protein
solutions were loaded and eluted individually, using the same gradient method. As shown
in Fig. 6.1a, the OVA sample has three elution peaks with retention times of 5.02, 5.95,
and 7.18 min, respectively. The multiple peaks from OVA increases the complexity (and
ambiguity) of the separation, and there are potential overlaps with the elution peaks of myo
(6.15 min) and BGG (6.98 min). Therefore, OVA was replaced with a protein of similar
retention time and molecular weight, prodicing only one distinctive elution peak for a
clearer chromatogram in the method optimization phase. Cytochrome c, cytc, was chosen
to replace OVA, and the protein mixture was made with 0.05, 0.2, 0.2, 0.2, 0.4 mg mL-1 of
VB12, cytc, myo, BGG, Tg, respectively. Fig. 6.1b presents the separation of the revised
protein mixture and the corresponding individual proteins by the PPY C-CP column. In the
chromatogram, relatively smaller molecule VB12 elutes early in the gradient, with the
larger proteins showing comparatively narrow elution peaks and eluted with clear temporal
resolution. There is a direct relationship between the retention times and the respective
proteins’ molecular weights, reflecting an increase in hydrophobicity based on the RP
mechanism. To be clear, one must consider the “hydrophibicity” in question is that of the
portion of the solute in contact with the fiber surface, the so-called hydrophobic foot.
Indeed, the elution profile for the least hydrophobic VB12, while at a short retention time,
is very broad as that molecule has a high level of surface contact area. Prior to the detailed
optimization, all five species were separated (resolution range 1.07-3.12) within 10 min
with the PPY fiber C-CP column.
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Gradient time optimization
To achieve separations with better resolution, parametric optimizations were
performed. In a previous study on protein separations with C-CP fiber column, separation
quality and resolution were shown to be affected by the gradient operation time.28 Gradient
rate effects the time frame over which the critical solvent concentrations releasing the
solutes from the fiber surface are passed.

Fig. 6.2. Representative chromatograms of the synthetic protein mixture separation as a function
of gradient operation time. The gradient time was varied at 6, 8, 12, 16, 20 min, respectively. 5 μL
of the 1.0 mg mL-1protein mixture was employed at flow rate of 0.5 mL min-1 with 0.1 % TFA in
mobile phase.

Here, the need to overcome multiple protein-surface interactions results in broader
peaks, Thus changes in gradient rates my reveal both chemical and physical kinetic
limitations. The mobile phase composition was changed from 100% mobile phase A
(100% DI water with 0.1% TFA) to 100% mobile phase B (100 % ACN with 0.1% TFA)
with varied gradient times. The gradient time was changed from the initial 10 min to cover
a range including 6 min, 8 min, 12 min, 16 min, and 20 min, with a constant solution flow
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rate of 0.5 mL min-1. As depicted in the representative chromatograms (Fig. 6.2), in
general, longer gradient times yield wider peaks and lower absorbance responses with the
extension of retention times. The reduced peak absorbance values reflects the broader
bands and increased solute dilution with time. The response for VB12, where longer
gradients greatly distort the peak profile, reveal trade-offs in clarity and peak elution
complexity. With shorter gradient times (6 min and 8 min), though narrower peaks were
shown, the myo, BGG, and Tg peaks tend to co-elute, indicating that the desorption process
is kinetically limited.
Table 6.2. Determined resolution values1 of adjacent solute peaks for the protein mixture separation
at different gradient times (Fig. 6.2). Injection volume = 5 μL. (n=3)

The resolution of the adjacent peak pairs were calculated and shown in Table 6.2.
Among all the gradient times, 12 min yields the highest resolution values, except for the
resolution between BGG and Tg peaks when 16 min excels. For the sake of throughput
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and nominally better resolution, 12 min was determined to be best compromise gradient
time.
Flow rate optimization
Previous studies of the protein separations with PPY C-CP fiber columns showed
that increasing the elution flow rate can positively affect the separation quality and
resolution.12 The reason for this improvement is the narrowing of peak widths via lessened
amounts of longitudinal diffusion (van Deemter B-term), without paying a kinetic penalty
due to solution–solid mass transfer limitations (van Deemter C-term),30-31 as would be the
case in porous bed support phases.

Fig. 6.3. Representative chromatograms of the synthetic protein mixture separation as a function
of mobile phase flow rate. The flow rate was varied at 0.2, 0.4, 0.6, 0.8, and 1.0 mL min-1,
respectively. 5 μL of 1.0 mg mL-1protein mixture was employed with a 12 min gradient from mobile
phase A (DI water with 0.1 % TFA ) to mobile phase B (ACN with 0.1 % TFA )

Thus, the throughput and efficiency are improved. Herein, to assess the effects of
the flow rates on the separation of proteins with wide-ranging molecular weights, 5 μL of
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protein mixture sample was loaded and eluted varying flow rates (0.2, 0.4, 0.6, 0.8,1.0 mL
min−1) with a constant gradient time of 12 min. As seen in Fig. 6.3, higher flow rates lead
to earlier elution times and a weaker peak absorbance response. Such phenomena have
been consistently seen in previous C-CP fiber protein separations.20-21 The shorter elution
times reflect a two-fold effect. First, and easily imagined, the post-elution transit times are
reduced. Second, and a very fundamental effect, the critical gradient concentrations (%B)
actually are reduced at high linear velocities, as a consequence of greater levels of solvation
while the proteins are adsorbed on the surface. The loss in peak absorbance responsivity
is the simple result of increase solute dilution as the greater mobile phase flow rates. The
resolution values of the adjacent peaks were calculated and are presented in Table 6.3.
When the flow rate increases from 0.2 mL min-1 to 0.6 mL min-1, the resolution values tend
to increase, while beyond 0.6 mL min-1 when the absorbance responses become weak,
with the resolution values starting to decrease due to the ill-defined peak responses.
Therefore, 0.6 mL min-1 was determined to be the optimum flow rate.
Table 6.3. Resolution values of adjacent peaks for the protein mixture separation at different flow
rates. Injection volume = 5 μL. (n=3)
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Mobile phase modifier composition optimization
TFA is a widely employed mobile phase additive for RPLC of proteins. TFA
provides a low-pH mobile phase (0.1 % TFA solution has pH of ~1.9), acting as an ionpairing reagent with biomolecules, and is sufficiently volatile to use with mass
spectrometric or evaporative light scattering detectors.32 Varying the concentration of TFA
can provide a means of changing selectivity because the more positively charged (or charge
neutralized) peptides and proteins tend to be more preferentially retained on the
hydrophobic surfaces with higher TFA concentrations.33 Herein, to study the effects of
TFA concentration on the separation of proteins onteh PPY phase, 5 μL of a 0.1 mg mL-1
protein mixture was loaded and eluted at the optimized gradient time (12 min) and flow
rate (0.6 mL min−1), with different mobile phase (both A and B) TFA concentrations (0.5%,
1%, and 2%).

Fig. 6.4. Representative chromatograms of synthetics protein mixture separation as a function of
TFA concentration in mobile phase. The TFA concentration in mobile phase varied at 0.5%, 1.0%
and 2.0%, respectively. 5 μL of 1.0 mg mL-1protein mixture was employed at a flow rate 0.6 mL
min-1 with a 12 min gradient.
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Representative chromatograms are shown in Fig. 6.4, with the respective resolution
values for the adjacent peaks calculated and shown in Table 6.4. With 0.1% TFA, the
peaks of myo, BGG, and Tg were sharper than those in 0.05% exhibiting greater resolution
(Table 6.4). As the concentration continues to increase to 0.2%, even though the peaks of
VB12, cytc and myo were sharper with better resolution, the signal responses of Glo and
Tg are very low. The poor recoveries here suggest that those large proteins are irreversibly
bound, perhaps being caused by the denaturing of the large proteins at lower pH. Thus,
0.1% TFA is selected as the optimal concentration in mobile phases.
Table 6.4. Resolution values for adjacent peaks for the protein mixture separation at different TFA
concentrations. Injection volume = 5 μL. (n=3)

Comparison of the PPY C-CP column with commercial C4 and SEC columns for protein
mixture separation
In the aforementioned discussion, the PPY C-CP column shows great potential in
the separation of proteins with wide-ranging molecular weights with the optimized
separation conditions. To further benchmark the capabilities of the PPY C-CP column, it
was compared with the commercial protein columns (C4 and SEC) applied to the same
sample protein mixtures. Both the purchased SEC protein standard and the modified (OVA
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replace by cyt c) protein mixture were used for the comparison. Fig. 6.5 illustrates the
chromatograms of the separation of the commercial SEC protein test mixture and the
corresponding single proteins for the three different column types.

Fig. 6.5. Chromatography of SEC protein test mixture separation with a) PPY C-CP column, b) C4
column, and c) SEC column. 5 μL of individual proteins (0.05, 0.2, 0.2, 0.2, 0.4 mg mL-1 of Vit
B12, chicken ovalbumin, equine myoglobin, bovine gamma-globulin, thyroglobulin, respectively),
along the individual proteins. a) a12-min gradient (0.1% aqueous TFA to ACN + 0.1% TFA) was
performed with a flow rate 0.6 mL min-1, b) a 30-min gradient (0.1% aqueous TFA to 80% ACN +
0.1% TFA) was performed with a flow rate 0.4 mL min-1, and c) 100 mM phosphate was performed
for 20 min with a flow rate 0.86 mL min-1

The separation observed for the C-CP fiber column (Fig. 6.5a) is consistent with
what would be expected based on the previous separations, with the respective components
being well resolved, but with the OVA complicating the chromatograms as it presents
multiple peaks in the single-component separation. In the case of the commercial C4derivatized poroshell column (Fig. 6.5b), the OVA as well contributes a great deal to the
separation complexity, as does myo which presents multiple peaks. Very different from
the fiber column, though, the VB12 is not retained at all on the column, eluting in the void
volume. Perhaps surprisingly, while the highest mass Tg presents as an isolated peak, the

141

BGG elutes as a very broad diffuse peak, to which the OVA and Tg are superimposed in
the mixture chromatogram. Finally, the SEC separation (Fig. 6.5c) presents an elution
order which would be expected, from the highest-to-lowest molecular weight/sizes;
virtually the opposite of the two RP separations. As with the case of the RP separations,
there OVA produces more than one peak, but in addition, both myo and BGG produce
distinct, multiple peaks as well. The C4 RP separation does suggest multiple forms of myo
as well, but does not give this indication for the BGG. Reasons for the multiple, distinct
forms of these proteins include the existence of two distinct isoforms (as is known for
myo34), or potential agglomeration in solution.35

Fig. 6.6 Chromatography of proteins separation with a) PPY C-CP fiber column, b) C4 column,
and c) SEC column. 5 μL of individual proteins (0.05, 0.2, 0.2, 0.2, 0.4 mg mL-1 of Vit B12,
cytochrome c, equine myoglobin, bovine gamma-globulin, thyroglobulin, respectively), and these
five proteins mixture were loaded. a) a12-min gradient (0.1% aqueous TFA to ACN + 0.1% TFA)
was performed with a flow rate 0.6 mL min-1, b) a 30-min gradient (0.1% aqueous TFA to 80%
ACN + 0.1% TFA) was performed with a flow rate 0.4 mL min-1, and c) 100 mM phosphate was
performed for 20 min with a flow rate 0.86 mL min-1

In order to remove the complicating factor of the multiple forms/impurities
introduced by the OVA, the synthetic mixture wherein OVA is replace with cty c was
evaluated on each column type. As expected for the PPY fiber separation (Fig. 6.6a), the
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switch from OVA to cyt c does yield a cleaner chromatogram.

Likewise, the

chromatogram of the mixture on commercial C4 column shows greater clarity, though with
myo yielding multiple peaks, the VB12 being unretained, and the BGG presenting itself as
a diffuse, broad band (Fig. 6.6b). It must be noted that BGG does yield a broad peak on
the fiber column as well, suggestive of that protein having a large contact area on the phase
surfaces. Finally, the separation of the mixture on the SEC column (Fig. 6.6c) is not
appreciably simplified in this case as myo and BGG still exhibit multiple peaks, especially
the peak at around 5.3 min indicating an overlap, with the cyt c showing virtually no
response.
Table 6.5. Resolution values for adjacent peaks for the protein mixture separation with different
columns. Injection volume = 5 μL. (n=3)

The cumulative separation resolution metrics for the mixture across the columns
are presented in Table 6.5. The C4 column shows great resolution on Cytc and myo,
however, the resolution of the BGG signal is not calculated due to its breadth. For the SEC
column, it seems that the resolutions between BGG peak and the adjacent peaks (myoBGG, and BGG-Tg) are higher than that from the PPY C-CP column. It is worth
mentioning that the resolution between BGG and myo was calculated by using peaks at 4.4
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min and 5.7 min, while there is a small peak in the middle of these two peaks. This means
although the the major peaks are well resolved in the chromatogram, the proteins may not
be well separated due to the existence of the overlapping peak at around 5.4 min. There is
the same issue when calculating the resolution between BGG and Tg peaks. The small peak
at 3.8 min in between the major peaks at 3.3 min and 4.4 min indicates possible overlap
between the two proteins, which is problemetic for the separation. As might be anticipated,
no single column yields optimum performance for each of the proteins in the suite, but
overall, the PPY C-CP column offers a great capability of the separation of proteins with
wide-ranging molecular weights.
6.5 Conclusions
In this study, an RPLC method for proteins with wide-ranging molecular weights
(1.4 to 660 kDa) separation using a PPY C-CP column has been compared with a
commercialized C4 column and a commercially available SEC column. The use of novel
PPY C-CP column fibers in a microbore column format allows for rapid processing and
separation on time scales of 5–10 min. The PPY C-CP column has shown great potential
in the separation of proteins with wide-ranging molecular weights (1.4 to 660 kDa) without
worrying about the loss of regeneration ability when dealing with small molecules
(common to SEC columns), and the denaturation of the proteins when the molecular weight
is too high (common issue with reversed-phase chromatography). Several experimental
parameters were evaluated and optimized, including gradient time (12 min), solvent flow
rate (0.6 mL min-1), and TFA concentration in the mobile phase (0.1%). Based on the
results of this study, the affordability (< $15 per column) and efficiency (< 10 min) of the
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separation of proteins with wide-ranging molecular weights can be significantly improved,
and the new method can be potentially adapted to applications in clinical and fundamental
biochemistry.
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CHAPTER VII
SUMMARY AND FUTURE WORK
7.1 Summary
These works have presented the methods development for the isolation and
quantification of exosomes, lentiviruses, and proteins. The traditional isolation and
quantification methods, the HIC method we used in these study as well as the capillarychanneled polymer (C-CP) fiber column are outlined in Chapter I. Due to the
preponderance of exosomes in many biological processes and the potential for their use in
clinical diagnostics and drug delivery, there is a critical demand for methods that provide
access to exosomes in diverse biological media.
Chapter II presents the study on the isolation and quantification of exosome from
human urine with polyester(PET) C-CP fiber column via hydrophobic interaction
chromatography (HIC) method with acetonitrile (ACN) as a modifier. Instead of the use of
multiple centrifugation and solid-phase extraction steps, sample volumes of hundreds of
microliter volumes are simply passed through standard 0.2-μm filters prior to injection.
HIC gradient programs of less than 15 min provide high levels of purity (isolation from
proteins, etc.) with a simple inter-separation cleaning protocol providing robust results
without carryover. The process has been verified via scanning electron microscopy (SEM)
before and after the capture of exosomes on the fiber surfaces. Sample load and elution
rates were optimized to affect high resolution and throughput. The procedure provides
purification and quantification of exosomes in a single operation, with the HIC
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chromatographic method and simple absorbance detection affected on a standard HPLC
platform.
Further study on the evaluation of exosome loading characteristics is presented in
Chapter III. A milder solvent modifier, glycerol, is used to replace the ACN. Then, a
glycerol-assisted step gradient HIC method for exosomes isolation from cellular milieu
media has been developed and characterized. The optimized method yields very high
exosome purity, as proteins and media components are either eluted prior to the target
vesicles or are not retained on the column at all. Binding capacities on the order of 1012
exosomes, in time frames of a few minutes, with efficiencies of >80% represent a stepfunction improvement in exosome processing technologies.
Other than urine and cell culture media, human plasma is a more complicated
exosome source. The co-extraction of free low-density lipoproteins (LDLs) and exosomes
has been a major challenge to an improved understanding and utilization of these important
exosomes in blood plasma. Indeed, this is a major complicating aspect in source the “pure”
vesicles. Chapter IV demonstrates the isolation of free LDLs from human plasma-derived
exosomes using a HIC process in a single unit operation on a PET C-CP fiber
chromatography column. In the method described herein, a step-gradient procedure
sequentially elutes spiked lipoproteins and blood plasma-originating exosomes in 10
minutes, with the LDLs excluded from the desired exosome fraction. TEM and ELISA
results demonstrated that LDL and exosomes were isolated in the first and second steps,
respectively.
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In Chapter V, because exosomes and lentiviruses have similar sizes and
hydrophobicity, the glycerol-assisted step gradient HIC method is revised and used for the
isolation of lentiviruses from cell culture media. Standard post-column absorbance
detection and quantitative polymerase chain reaction (qPCR) assays provide
complementary information about the efficiency of the processes. Ultimately, the two-step
gradient program can be effective for high purity and yield (>75%) of virus particles. SEM
imaging of fiber surfaces provides further insights into the on-column processes.
In Chapter VI, an RPLC method for proteins with wide-ranging molecular weights
(1.4 to 660 kDa) separation using a PPY C-CP column has been compared with a
commercialized C4 column and a commercially available SEC column. The use of novel
PPY C-CP column fibers in a microbore column format allows for rapid processing and
separation on time scales of 5–10 min. The PPY C-CP column has shown great potential
in the separation of proteins with wide-ranging molecular weights (1.4 to 660 kDa) without
worrying about the loss of regeneration ability when dealing with small molecules
(common to SEC columns), and the denaturation of the proteins when the molecular weight
is too high (common issue with reversed-phase chromatography).
7.2 Future work
The research presented in this dissertation developed methods on exosomes,
lentiviruses and protein isolation and quantification. Questions remain in terms of
mechanisms and potential applications. Regarding exosome and lentivirus isolation,
though it may be eventually realized that method could provide quantitative information of
particle densities, methods such as multiangle light scattering spectrometry (MALS) could
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be readily implemented post-column to assess particle size. The scale-up of the benchtop
methodology to industrial preparative-scale purification of virus particles is foreseeable
based on previous hydrodynamic studies of protein separations, increased column capacity
could be affected through either the use of longer columns of the same diameter or use of
larger-diameter columns packed to equivalent interstitial fractions.
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APPENDICES
Appendix A
Supporting Information for Chapter V
Table A-1. qPCR data of lentivirus in 50% glycerol, PBS and 40% acetonitrile with different
incubation times at 4°C. (n=3 replicates for each sample)
Ct number

Solvent

Average

% RSD

Trial 1

Trial 2

Trial 3

18.46

18.33

18.40

18.39

0.32

18.22

18.27

18.29

18.26

0.19

18.02

18.08

18.11

18.07

0.25

ACN 10 min

21.13

21.13

21.38

21.21

0.68

PBS 60 min

17.49

17.57

17.69

17.59

0.80

STD1

13.47

14.78

14.53

14.26

4.88

STD2

16.25

16.67

16.42

16.35

0.68

50% glycerol 10
min
50% glycerol 30
min
50% glycerol 60
min

Table A-2. qPCR data of RNA standard in 50% glycerol, PBS, 40% acetonitrile, and 2 M
ammonium sulfate without incubation at 4°C. (n=3 replicates for each sample)
Ct number

Solvent

Average

% RSD

90% Confidence
Interval

Trial 1

Trial 2

Trial 3

50% glycerol

21.27

20.81

21.63

21.24

1.9

[20.58, 21.96]

2M (NH4)2SO4

N/A

N/A

N/A

0

N/A

N/A

40% ACN

21.34

21.48

21.86

21.56

1.3

[21.11, 22.01]

PBS

21.19

21.65

21.60

21.48

1.2

[20.05, 21.91]

STD1

14.86

14.62

14.61

14.70

0.96

STD2

16.69

16.61

16.51

16.60

0.54
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Table A-3. qPCR data of the lentivirus in second-step elution. 20 µL injection of cell media (~1.2
x 105particles) into different (NH4)2SO4 concentrations in 1x PBS at as the initial solvent. Gradient
steps of 25% glycerol with 1 M (NH4)2SO4 at 1 min and 50% glycerol 5 min were performed (n=3
replicates for each sample)
(NH4)2SO4 Conc. in
Loading Step

Ct number

Average

% RSD

Trial 1

Trial 2

Trial 3

2M

34.63

34.57

34.44

34.55

0.28

1.5 M

28.50

27.58

28.74

28.27

2.2

1M

34.44

34.15

30.39

30.69

6.9

STD1

14.36

15.04

13.23

14.21

6.4

STD2

17.08

17.54

17.89

17.50

2.3

Table A-4. qPCR data of the lentivirus in second-step elution. 20 µL injection of cell media (~1.2
x 105 particles) into 1.5 M (NH4)2SO4 in 1x PBS at different glycerol concentrations as the initial
solvent. Gradient steps of 25% glycerol with 1 M (NH4)2SO4 at 1 min and 50% glycerol 5 min were
performed (n=3 replicates for each sample)
Glycerol Conc. in
Loading Step

Ct number

Average

% RSD

Trial 1

Trial 2

Trial 3

10%

27.63

25.60

25.00

26.08

5.3

15%

25.3

25.31

24.66

25.09

1.5

20%

27.34

26.97

26.91

27.07

0.86

25%

31.27

29.39

30.42

30.36

0.94

STD1

13.23

13.28

13.20

13.24

0.31

STD2

16.51

16.53

16.49

16.51

0.12
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Table A-5. qPCR data of the lentivirus in second-step elution. 20 µL injection of cell media (~1.2
x 105 particles) into 1.5 M (NH4)2SO4 in 1x PBS at and 15% glycerol concentrations as the initial
solvent. Gradient steps of different glycerol concentration with 1 M (NH4)2SO4 at 1 min and 50%
glycerol 5 min were performed. (n=3 replicates for each sample)
Glycerol Conc. in
first elution Step

Ct number

Average

% RSD

Trial 1

Trial 2

Trial 3

20%

28.37

28.53

28.60

28.50

0.41

25%

28.49

29.76

29.18

29.14

2.2

30%

30.36

29.53

28.52

29.47

3.1

35%

32.21

33.36

30.42

31.70

3.2

STD1

13.24

13.23

12.93

13.24

1.3

STD2

17.08

17.54

17.89

17.50

2.3
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